false Q3 2026 --02-28 0001498148 0001498148 2025-03-01 2025-11-30 0001498148 2026-01-12 0001498148 2025-11-30 0001498148 2025-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2025-11-30 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2025-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2025-11-30 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2025-11-30 0001498148 us-gaap:SeriesGPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2025-11-30 0001498148 us-gaap:SeriesEPreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2025-11-30 0001498148 us-gaap:SeriesFPreferredStockMember 2025-02-28 0001498148 2025-09-01 2025-11-30 0001498148 2024-09-01 2024-11-30 0001498148 2024-03-01 2024-11-30 0001498148 AITX:CostOfGoodsSoldMember 2025-09-01 2025-11-30 0001498148 AITX:CostOfGoodsSoldMember 2024-09-01 2024-11-30 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2025-11-30 0001498148 AITX:CostOfGoodsSoldMember 2024-03-01 2024-11-30 0001498148 AITX:DepreciationAndAmortizationMember 2025-09-01 2025-11-30 0001498148 AITX:DepreciationAndAmortizationMember 2024-09-01 2024-11-30 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2025-11-30 0001498148 AITX:DepreciationAndAmortizationMember 2024-03-01 2024-11-30 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-02-29 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-02-29 0001498148 us-gaap:CommonStockMember 2024-02-29 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001498148 us-gaap:RetainedEarningsMember 2024-02-29 0001498148 2024-02-29 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-05-31 0001498148 us-gaap:CommonStockMember 2024-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-05-31 0001498148 us-gaap:RetainedEarningsMember 2024-05-31 0001498148 2024-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-08-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-08-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-08-31 0001498148 us-gaap:CommonStockMember 2024-08-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-08-31 0001498148 us-gaap:RetainedEarningsMember 2024-08-31 0001498148 2024-08-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:CommonStockMember 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-02-28 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-05-31 0001498148 2025-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-08-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-08-31 0001498148 us-gaap:CommonStockMember 2025-08-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-08-31 0001498148 us-gaap:RetainedEarningsMember 2025-08-31 0001498148 2025-08-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-03-01 2024-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2024-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-03-01 2024-05-31 0001498148 us-gaap:CommonStockMember 2024-03-01 2024-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-03-01 2024-05-31 0001498148 us-gaap:RetainedEarningsMember 2024-03-01 2024-05-31 0001498148 2024-03-01 2024-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-06-01 2024-08-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-06-01 2024-08-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-06-01 2024-08-31 0001498148 us-gaap:CommonStockMember 2024-06-01 2024-08-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-06-01 2024-08-31 0001498148 us-gaap:RetainedEarningsMember 2024-06-01 2024-08-31 0001498148 2024-06-01 2024-08-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-09-01 2024-11-30 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-09-01 2024-11-30 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-09-01 2024-11-30 0001498148 us-gaap:CommonStockMember 2024-09-01 2024-11-30 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-09-01 2024-11-30 0001498148 us-gaap:RetainedEarningsMember 2024-09-01 2024-11-30 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2025-05-31 0001498148 2025-03-01 2025-05-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-06-01 2025-08-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-06-01 2025-08-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-06-01 2025-08-31 0001498148 us-gaap:CommonStockMember 2025-06-01 2025-08-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-06-01 2025-08-31 0001498148 us-gaap:RetainedEarningsMember 2025-06-01 2025-08-31 0001498148 2025-06-01 2025-08-31 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-09-01 2025-11-30 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-09-01 2025-11-30 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-09-01 2025-11-30 0001498148 us-gaap:CommonStockMember 2025-09-01 2025-11-30 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-09-01 2025-11-30 0001498148 us-gaap:RetainedEarningsMember 2025-09-01 2025-11-30 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2024-11-30 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-11-30 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-11-30 0001498148 us-gaap:CommonStockMember 2024-11-30 0001498148 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0001498148 us-gaap:RetainedEarningsMember 2024-11-30 0001498148 2024-11-30 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-11-30 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-11-30 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-11-30 0001498148 us-gaap:CommonStockMember 2025-11-30 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-11-30 0001498148 us-gaap:RetainedEarningsMember 2025-11-30 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2017-07-25 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesEPreferredStockMember 2017-08-27 2017-08-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesFPreferredStockMember 2017-08-27 2017-08-28 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember 2025-06-01 2025-06-30 0001498148 srt:ControllerMember 2025-03-01 2025-11-30 0001498148 srt:ControllerMember 2025-11-30 0001498148 srt:ControllerMember 2025-02-28 2025-02-28 0001498148 srt:ControllerMember 2025-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:OneCustomerMember 2025-09-01 2025-11-30 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:OneCustomerMember 2024-09-01 2024-11-30 0001498148 AITX:OneCustomerMember 2025-11-30 0001498148 AITX:OneCustomerMember 2024-11-30 0001498148 AITX:IncentiveCompensationPlanMember 2025-09-01 2025-11-30 0001498148 AITX:IncentiveCompensationPlanMember 2024-12-01 2025-02-28 0001498148 us-gaap:ComputerEquipmentMember srt:MinimumMember 2025-11-30 0001498148 us-gaap:ComputerEquipmentMember srt:MaximumMember 2025-11-30 0001498148 us-gaap:OfficeEquipmentMember 2025-11-30 0001498148 AITX:ManufacturingEquipmentMember 2025-11-30 0001498148 AITX:WarehouseEquipmentMember 2025-11-30 0001498148 us-gaap:ToolsDiesAndMoldsMember 2025-11-30 0001498148 AITX:DemoDevicesMember 2025-11-30 0001498148 us-gaap:VehiclesMember 2025-11-30 0001498148 us-gaap:LeaseholdImprovementsMember 2025-11-30 0001498148 us-gaap:FairValueInputsLevel1Member 2025-11-30 0001498148 us-gaap:FairValueInputsLevel2Member 2025-11-30 0001498148 us-gaap:FairValueInputsLevel3Member 2025-11-30 0001498148 us-gaap:FairValueInputsLevel1Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2025-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2025-02-28 0001498148 AITX:SimpleAgreementForFutureEquityMember 2022-12-23 0001498148 2024-06-03 2024-06-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:CommonStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:WarrantMember 2025-01-03 2025-01-03 0001498148 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesAPreferredStockMember 2025-02-28 0001498148 us-gaap:WarrantMember 2025-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-09-01 2025-11-30 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2025-11-30 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2024-09-01 2024-11-30 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2024-03-01 2024-11-30 0001498148 us-gaap:AutomobilesMember 2025-11-30 0001498148 us-gaap:AutomobilesMember 2025-02-28 0001498148 AITX:DemoDevicesMember 2025-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2025-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2025-11-30 0001498148 us-gaap:MachineryAndEquipmentMember 2025-02-28 0001498148 us-gaap:ComputerEquipmentMember 2025-11-30 0001498148 us-gaap:ComputerEquipmentMember 2025-02-28 0001498148 us-gaap:OfficeEquipmentMember 2025-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2025-11-30 0001498148 us-gaap:FurnitureAndFixturesMember 2025-02-28 0001498148 AITX:WarehouseEquipmentMember 2025-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2025-02-28 0001498148 AITX:FixedAssetsMember 2025-09-01 2025-11-30 0001498148 AITX:FixedAssetsMember 2024-09-01 2024-11-30 0001498148 AITX:FixedAssetsMember 2025-03-01 2025-11-30 0001498148 AITX:FixedAssetsMember 2024-03-01 2024-11-30 0001498148 AITX:RevenueEarningDevicesMember 2025-09-01 2025-11-30 0001498148 AITX:RevenueEarningDevicesMember 2024-09-01 2024-11-30 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2025-11-30 0001498148 AITX:RevenueEarningDevicesMember 2024-03-01 2024-11-30 0001498148 us-gaap:InvestorMember 2019-02-01 2019-02-01 0001498148 us-gaap:InvestorMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorOneMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorOneMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorTwoMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorTwoMember 2020-02-29 2020-02-29 0001498148 us-gaap:InvestorMember 2025-03-01 2025-11-30 0001498148 AITX:InvestorOneMember 2019-11-18 0001498148 AITX:InvestorOneMember 2019-11-18 2019-11-18 0001498148 us-gaap:InvestorMember 2020-02-29 0001498148 AITX:InvestorOneMember 2020-05-31 0001498148 AITX:InvestorTwoMember 2019-12-30 0001498148 AITX:InvestorTwoMember 2019-12-30 2019-12-30 0001498148 AITX:InvestorTwoMember 2020-02-29 0001498148 us-gaap:InvestorMember 2020-04-22 0001498148 us-gaap:InvestorMember 2020-04-22 2020-04-22 0001498148 us-gaap:InvestorMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:AgreementOneMember 2019-02-01 0001498148 us-gaap:InvestorMember AITX:AgreementTwoMember 2019-11-18 0001498148 us-gaap:InvestorMember AITX:AgreementThreeMember 2020-07-01 0001498148 us-gaap:InvestorMember 2020-08-27 0001498148 us-gaap:InvestorMember 2020-08-31 2020-08-31 0001498148 us-gaap:InvestorMember 2020-08-27 2020-08-27 0001498148 2021-03-01 0001498148 us-gaap:InvestorMember srt:MaximumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember srt:MinimumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-05-31 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-05-31 0001498148 us-gaap:InvestorMember 2025-11-30 0001498148 us-gaap:InvestorMember 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2025-11-30 0001498148 us-gaap:RelatedPartyMember 2025-02-28 0001498148 us-gaap:RelatedPartyMember 2025-03-01 2025-11-30 0001498148 us-gaap:RelatedPartyMember 2024-03-01 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2025-11-30 0001498148 srt:ChiefExecutiveOfficerMember 2023-12-01 2023-12-31 0001498148 srt:ChiefExecutiveOfficerMember 2025-02-28 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-09-01 2025-11-30 0001498148 srt:ChiefExecutiveOfficerMember 2024-09-01 2024-11-30 0001498148 srt:ChiefExecutiveOfficerMember 2024-03-01 2024-11-30 0001498148 srt:ChiefExecutiveOfficerMember us-gaap:SeriesGPreferredStockMember 2025-11-30 0001498148 AITX:PromissoryNotePayableOneMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableOneMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwoMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwoMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThreeMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThreeMember 2025-11-30 0001498148 AITX:PromissoryNotePayableFourMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableFourMember 2025-11-30 0001498148 AITX:PromissoryNotePayableFiveMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableFiveMember 2025-11-30 0001498148 AITX:PromissoryNotePayableSixMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableSixMember 2025-11-30 0001498148 AITX:PromissoryNotePayableSevenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableSevenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableEightMember 2025-11-30 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableNineMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableElevenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentySixMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2025-11-30 0001498148 AITX:PromissoryNotePayableTwoMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2023-03-01 2024-02-29 0001498148 AITX:PromissoryNotePayableThreeMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSixMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSevenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableNineMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableNineMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableTenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableElevenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwelveMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThirteenMember srt:DirectorMember us-gaap:SeriesFPreferredStockMember 2025-03-01 2025-11-30 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 2025-04-25 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-25 0001498148 AITX:PromissoryNotePayableFourteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableFifteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSeventeenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableNineteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:LenderMember us-gaap:SeriesFPreferredStockMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-10-26 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFWarrantsMember AITX:OctoberThirtyOneTwentyThirtyThreeMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-02-29 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySixMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentySixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNotePayableThirtyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2023-11-30 2023-11-30 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-01 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2024-07-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember AITX:LenderMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtyTwoMember AITX:LenderMember 2024-03-08 2024-03-08 0001498148 AITX:PromissoryNotePayableThirtySixMember 2025-08-25 2025-08-25 0001498148 AITX:PromissoryNotePayableFourtyMember 2025-11-30 0001498148 AITX:PromissoryNotePayableFourtyMember 2025-03-01 2025-11-30 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-10 2025-05-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-08-09 2025-08-09 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-08-09 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-09 2025-08-09 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-25 2025-08-25 0001498148 2025-08-25 2025-08-25 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-11-07 2025-11-07 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-11-07 0001498148 2025-09-22 2025-09-22 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-09-22 2025-09-22 0001498148 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember 2025-12-05 2025-12-05 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-11-30 0001498148 us-gaap:CommonStockMember 2025-10-14 0001498148 us-gaap:CommonStockMember 2025-10-15 0001498148 us-gaap:CommonStockMember 2025-03-01 2025-11-30 0001498148 AITX:CommonStockActivityMember 2025-03-01 2025-11-30 0001498148 AITX:CommonStockActivityMember 2025-11-30 0001498148 AITX:CommonStockWarrantMember 2025-09-01 2025-11-30 0001498148 AITX:CommonStockWarrantMember 2024-09-01 2024-11-30 0001498148 AITX:CommonStockWarrantMember 2025-03-01 2025-11-30 0001498148 AITX:CommonStockWarrantMember 2024-03-01 2024-11-30 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2024-03-01 2025-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-03-01 2025-11-30 0001498148 AITX:SeriesFPreferredWarrantsMember 2025-11-30 0001498148 AITX:CommonStockWarrantMember 2025-02-28 0001498148 AITX:CommonStockWarrantMember 2024-03-01 2025-02-28 0001498148 AITX:CommonStockWarrantMember 2025-03-01 2025-11-30 0001498148 AITX:CommonStockWarrantMember 2025-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2025-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2025-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2025-11-30 0001498148 2025-06-01 2025-06-30 0001498148 2025-08-01 2025-08-01 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-04 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-10 2025-03-11 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 0001498148 us-gaap:ConvertibleDebtMember 2025-09-01 2025-11-30 0001498148 us-gaap:ConvertibleDebtMember 2024-09-01 2024-11-30 0001498148 us-gaap:ConvertibleDebtMember 2025-03-01 2025-11-30 0001498148 us-gaap:ConvertibleDebtMember 2024-03-01 2024-11-30 0001498148 AITX:PreferredSharesMember 2025-09-01 2025-11-30 0001498148 AITX:PreferredSharesMember 2024-09-01 2024-11-30 0001498148 AITX:PreferredSharesMember 2025-03-01 2025-11-30 0001498148 AITX:PreferredSharesMember 2024-03-01 2024-11-30 0001498148 us-gaap:WarrantMember 2025-09-01 2025-11-30 0001498148 us-gaap:WarrantMember 2024-09-01 2024-11-30 0001498148 us-gaap:WarrantMember 2025-03-01 2025-11-30 0001498148 us-gaap:WarrantMember 2024-03-01 2024-11-30 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-09-01 2025-11-30 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2024-09-01 2024-11-30 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2025-11-30 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2024-03-01 2024-11-30 0001498148 us-gaap:SeriesCPreferredStockMember 2025-09-01 2025-11-30 0001498148 us-gaap:SeriesCPreferredStockMember 2024-09-01 2024-11-30 0001498148 us-gaap:SeriesCPreferredStockMember 2025-03-01 2025-11-30 0001498148 us-gaap:SeriesCPreferredStockMember 2024-03-01 2024-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2025-09-01 2025-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2024-09-01 2024-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2025-11-30 0001498148 us-gaap:EmployeeStockOptionMember 2024-03-01 2024-11-30 0001498148 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2025-12-01 2026-01-14 0001498148 us-gaap:SubsequentEventMember 2025-12-01 2026-01-14 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-09 2025-12-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-17 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-17 2025-12-17 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-22 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2025-12-22 2025-12-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

false Q1 --02-28 0001498148 0001498148 2026-03-01 2026-05-31 0001498148 2026-07-13 0001498148 2026-05-31 0001498148 2026-02-28 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-05-31 0001498148 AITX:SeriesBRedeemablePreferredStockMember 2026-02-28 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-05-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesGPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember 2026-02-28 0001498148 2025-03-01 2025-05-31 0001498148 AITX:CostOfGoodsSoldMember 2026-03-01 2026-05-31 0001498148 AITX:CostOfGoodsSoldMember 2025-03-01 2025-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2026-03-01 2026-05-31 0001498148 AITX:DepreciationAndAmortizationMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-02-28 0001498148 us-gaap:CommonStockMember 2025-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-02-28 0001498148 us-gaap:RetainedEarningsMember 2025-02-28 0001498148 2025-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-02-28 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-02-28 0001498148 us-gaap:CommonStockMember 2026-02-28 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-02-28 0001498148 us-gaap:RetainedEarningsMember 2026-02-28 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-03-01 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-03-01 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2025-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-05-31 0001498148 us-gaap:CommonStockMember 2025-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2025-05-31 0001498148 us-gaap:RetainedEarningsMember 2025-05-31 0001498148 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember AITX:TemporaryEquityMember 2026-05-31 0001498148 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-05-31 0001498148 us-gaap:CommonStockMember 2026-05-31 0001498148 us-gaap:AdditionalPaidInCapitalMember 2026-05-31 0001498148 us-gaap:RetainedEarningsMember 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2017-07-25 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesEPreferredStockMember 2017-08-27 2017-08-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember us-gaap:SeriesFPreferredStockMember 2017-08-27 2017-08-28 0001498148 us-gaap:CommonStockMember AITX:EquityFinancingAgreementMember us-gaap:SubsequentEventMember 2026-06-23 2026-06-23 0001498148 srt:ControllerMember 2026-03-01 2026-05-31 0001498148 srt:ControllerMember 2026-05-31 0001498148 srt:ControllerMember 2025-03-01 2026-02-28 0001498148 srt:ControllerMember 2025-02-28 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:TwoCustomerMember 2026-03-01 2026-05-31 0001498148 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AITX:ThreeCustomerMember 2024-03-01 2025-02-28 0001498148 AITX:TwoCustomerMember 2026-05-31 0001498148 AITX:OneCustomerMember 2025-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2026-03-01 2026-05-31 0001498148 AITX:IncentiveCompensationPlanMember 2025-03-01 2025-05-31 0001498148 us-gaap:ComputerEquipmentMember srt:MinimumMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:OfficeEquipmentMember 2026-05-31 0001498148 AITX:ManufacturingEquipmentMember 2026-05-31 0001498148 AITX:WarehouseEquipmentMember 2026-05-31 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-05-31 0001498148 AITX:DemoDevicesMember 2026-05-31 0001498148 us-gaap:VehiclesMember 2026-05-31 0001498148 us-gaap:LeaseholdImprovementsMember 2026-05-31 0001498148 us-gaap:FairValueInputsLevel1Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel2Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel3Member 2026-05-31 0001498148 us-gaap:FairValueInputsLevel1Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel2Member 2026-02-28 0001498148 us-gaap:FairValueInputsLevel3Member 2026-02-28 0001498148 AITX:SimpleAgreementForFutureEquityMember 2022-12-23 0001498148 2024-06-03 2024-06-03 0001498148 us-gaap:SeriesAPreferredStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:CommonStockMember 2025-01-03 2025-01-03 0001498148 us-gaap:WarrantMember 2025-01-03 2025-01-03 0001498148 2024-03-01 2025-02-28 0001498148 us-gaap:SeriesAPreferredStockMember 2025-02-28 0001498148 us-gaap:WarrantMember 2025-02-28 0001498148 2025-03-01 2026-02-28 0001498148 us-gaap:AutomobilesMember 2026-05-31 0001498148 us-gaap:AutomobilesMember 2026-02-28 0001498148 AITX:DemoDevicesMember 2026-02-28 0001498148 us-gaap:ToolsDiesAndMoldsMember 2026-02-28 0001498148 us-gaap:MachineryAndEquipmentMember 2026-05-31 0001498148 us-gaap:MachineryAndEquipmentMember 2026-02-28 0001498148 us-gaap:ComputerEquipmentMember 2026-05-31 0001498148 us-gaap:ComputerEquipmentMember 2026-02-28 0001498148 us-gaap:OfficeEquipmentMember 2026-02-28 0001498148 us-gaap:FurnitureAndFixturesMember 2026-05-31 0001498148 us-gaap:FurnitureAndFixturesMember 2026-02-28 0001498148 AITX:WarehouseEquipmentMember 2026-02-28 0001498148 us-gaap:LeaseholdImprovementsMember 2026-02-28 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2026-03-01 2026-05-31 0001498148 AITX:RoboticAssistanceDevicesLLCMember 2025-03-01 2025-05-31 0001498148 AITX:FixedAssetsMember 2026-03-01 2026-05-31 0001498148 AITX:FixedAssetsMember 2025-03-01 2025-05-31 0001498148 AITX:RevenueEarningDevicesMember 2026-03-01 2026-05-31 0001498148 AITX:RevenueEarningDevicesMember 2025-03-01 2025-05-31 0001498148 us-gaap:InvestorMember 2019-02-01 2019-02-01 0001498148 us-gaap:InvestorMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorOneMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorOneMember 2020-02-29 2020-02-29 0001498148 AITX:InvestorTwoMember 2019-05-09 2019-05-09 0001498148 AITX:InvestorTwoMember 2020-02-29 2020-02-29 0001498148 us-gaap:InvestorMember 2026-03-01 2026-05-31 0001498148 AITX:InvestorOneMember 2019-11-18 0001498148 AITX:InvestorOneMember 2019-11-18 2019-11-18 0001498148 us-gaap:InvestorMember 2020-02-29 0001498148 AITX:InvestorOneMember 2020-05-31 0001498148 AITX:InvestorTwoMember 2019-12-30 0001498148 AITX:InvestorTwoMember 2019-12-30 2019-12-30 0001498148 AITX:InvestorTwoMember 2020-02-29 0001498148 us-gaap:InvestorMember 2020-04-22 0001498148 us-gaap:InvestorMember 2020-04-22 2020-04-22 0001498148 us-gaap:InvestorMember 2020-07-01 2020-07-01 0001498148 us-gaap:InvestorMember AITX:AgreementOneMember 2019-02-01 0001498148 us-gaap:InvestorMember AITX:AgreementTwoMember 2019-11-18 0001498148 us-gaap:InvestorMember AITX:AgreementThreeMember 2020-07-01 0001498148 us-gaap:InvestorMember 2020-08-27 0001498148 us-gaap:InvestorMember 2020-08-31 2020-08-31 0001498148 us-gaap:InvestorMember 2020-08-27 2020-08-27 0001498148 2021-03-01 0001498148 us-gaap:InvestorMember srt:MaximumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember srt:MinimumMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-03-01 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-05-31 0001498148 us-gaap:InvestorMember us-gaap:SeriesFPreferredStockMember 2021-03-01 2021-05-31 0001498148 us-gaap:InvestorMember 2026-05-31 0001498148 us-gaap:InvestorMember 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2026-02-28 0001498148 us-gaap:RelatedPartyMember 2026-03-01 2026-05-31 0001498148 us-gaap:RelatedPartyMember 2024-03-01 2025-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2026-03-01 2026-05-31 0001498148 srt:ChiefExecutiveOfficerMember 2023-12-01 2023-12-31 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2026-02-28 0001498148 srt:ChiefExecutiveOfficerMember 2025-03-01 2025-05-31 0001498148 srt:ChiefExecutiveOfficerMember us-gaap:SeriesGPreferredStockMember 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableElevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwelveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFourteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFifteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSixteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableSeventeenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableEighteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableNineteenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementMember 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:PurchaseAgreementOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableTwentyNineMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyTwoMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyThreeMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFourMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyFiveMember 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-03-01 2026-05-31 0001498148 AITX:BusinessLoanMember 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySixMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtySevenMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableThirtyNineMember 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteOneMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-03-01 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteFiveMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSevenMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-03-01 2026-05-31 0001498148 AITX:PromissoryNotePayableFortyTwoMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember 2026-05-05 2026-05-05 0001498148 AITX:PromissoryNotePayableTwoMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableTwoMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTwoMember 2025-12-10 0001498148 AITX:PromissoryNotePayableThreeMember 2023-03-01 2024-02-29 0001498148 AITX:PromissoryNotePayableThreeMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableThreeMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableThreeMember 2025-11-24 0001498148 AITX:PromissoryNotePayableThreeMember 2026-02-08 2026-02-08 0001498148 AITX:PromissoryNotePayableFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFiveMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableFiveMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSixMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSevenMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableSevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2024-03-01 0001498148 AITX:PromissoryNotePayableEightMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEightMember 2025-02-11 2025-02-11 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-28 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 0001498148 AITX:PromissoryNotePayableEightMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableNineMember 2025-03-05 2025-03-05 0001498148 AITX:PromissoryNotePayableNineMember 2022-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableNineMember 2023-11-28 2023-11-28 0001498148 AITX:PromissoryNotePayableNineMember 2024-03-01 0001498148 AITX:PromissoryNotePayableNineMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableNineMember 2025-11-24 0001498148 AITX:PromissoryNotePayableTenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableTenMember 2025-03-28 0001498148 AITX:PromissoryNotePayableTenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2021-03-01 2022-02-28 0001498148 AITX:PromissoryNotePayableElevenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableElevenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableElevenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableElevenMember 2025-03-01 2026-02-28 0001498148 AITX:PromissoryNotePayableTwelveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwelveMember 2025-11-24 0001498148 AITX:PromissoryNotePayableThirteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableThirteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableFourteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableFourteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableFifteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableFifteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSixteenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableSixteenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableSeventeenMember 2023-11-29 2023-11-29 0001498148 AITX:PromissoryNotePayableSeventeenMember 2025-04-16 2025-04-16 0001498148 AITX:PromissoryNotePayableEighteenMember AITX:LenderMember 2022-10-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2022-10-28 0001498148 AITX:PromissoryNotePayableEighteenMember AITX:LenderMember us-gaap:SeriesFPreferredStockMember 2022-10-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2022-10-26 2022-10-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2025-11-24 0001498148 AITX:PromissoryNotePayableEighteenMember 2024-02-29 0001498148 AITX:PromissoryNotePayableEighteenMember AITX:SeriesFPreferredshareWarrantsMember 2022-10-28 0001498148 AITX:PromissoryNotePayableEighteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableNineteenMember 2022-11-09 0001498148 AITX:PromissoryNotePayableNineteenMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-09 0001498148 AITX:PromissoryNotePayableNineteenMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-10 0001498148 AITX:PromissoryNotePayableTwentyMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyOneMember AITX:SeriesFPreferredshareWarrantsMember 2022-11-15 0001498148 AITX:PromissoryNotePayableTwentyOneMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyTwoMember AITX:SeriesFPreferredshareWarrantsMember 2023-01-11 0001498148 AITX:PromissoryNotePayableTwentyTwoMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentyThreeMember AITX:SeriesFPreferredshareWarrantsMember 2023-02-06 0001498148 AITX:PromissoryNotePayableTwentyThreeMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentyFourMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-05 0001498148 AITX:PromissoryNotePayableTwentyFourMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyFiveMember AITX:SeriesFPreferredshareWarrantsMember 2023-04-20 0001498148 AITX:PromissoryNotePayableTwentyFiveMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySixMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentySixMember AITX:SeriesFPreferredshareWarrantsMember 2023-05-11 0001498148 AITX:PromissoryNotePayableTwentySixMember 2024-03-01 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2023-10-27 0001498148 AITX:PromissoryNotePayableTwentySevenMember AITX:SeriesFPreferredshareWarrantsMember 2023-10-27 0001498148 AITX:PromissoryNotePayableTwentySevenMember 2024-03-01 0001498148 AITX:PurchaseAgreementMember AITX:LenderMember 2023-11-30 0001498148 AITX:PurchaseAgreementMember AITX:LenderMember 2023-11-30 2023-11-30 0001498148 AITX:PurchaseAgreementMember AITX:LenderMember 2024-07-01 2024-07-31 0001498148 AITX:PurchaseAgreementMember AITX:LenderMember 2024-07-31 0001498148 AITX:PurchaseAgreementMember AITX:LenderMember 2025-04-16 2025-04-16 0001498148 AITX:PurchaseAgreementOneMember AITX:LenderMember 2024-03-08 0001498148 AITX:PurchaseAgreementOneMember AITX:LenderMember 2024-03-08 2024-03-08 0001498148 AITX:PurchaseAgreementOneMember AITX:LenderMember 2023-11-30 2023-11-30 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2025-08-25 2025-08-25 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementMember 2025-03-01 2026-02-28 0001498148 AITX:BusinessLoanMember 2025-12-17 2025-12-17 0001498148 AITX:BusinessLoanMember 2025-12-17 0001498148 AITX:BusinessLoanMember 2025-03-01 2026-02-28 0001498148 AITX:BusinessLoanMember 2026-02-28 0001498148 AITX:ConvertibleNoteTwoMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteTwoMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteThreeMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteFourMember srt:MaximumMember 2026-05-31 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2026-04-13 2026-04-13 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 0001498148 AITX:FutureReceivablesPurchaseAndSaleAgreementOneMember 2025-12-17 2025-12-17 0001498148 AITX:ConvertibleNoteFiveMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember srt:MaximumMember 2026-05-31 0001498148 AITX:ConvertibleNoteSixMember 2025-03-01 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MinimumMember 2026-05-31 0001498148 AITX:ConvertibleNoteEightMember srt:MaximumMember 2026-05-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-10 2025-02-10 0001498148 2025-02-10 2025-02-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-10 2025-05-10 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-08-09 0001498148 AITX:SeriesBAndCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-09 2025-08-09 0001498148 AITX:SeriesCRedeemablePreferredStockMember AITX:TemporaryEquityMember 2025-08-25 2025-08-25 0001498148 2025-08-25 2025-08-25 0001498148 2025-09-30 2025-09-30 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-01 2025-12-31 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 2025-12-31 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001498148 2026-01-01 2026-01-31 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-01-01 2026-01-31 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MaximumMember 2025-09-01 2025-09-30 0001498148 AITX:SeriesCRedeemablePreferredStockMember srt:MinimumMember 2025-09-01 2025-09-30 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-28 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-02-01 2026-02-28 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-03-19 2026-03-19 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-06 2026-05-06 0001498148 AITX:SeriesCConvertibleRedeemablePreferredStockMember us-gaap:PreferredStockMember 2026-05-12 2026-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2025-05-12 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-05-31 0001498148 2026-03-18 0001498148 2026-03-19 0001498148 2026-02-05 2026-02-05 0001498148 AITX:CommonStockActivityMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockActivityOneMember 2026-03-01 2026-05-31 0001498148 2026-03-25 0001498148 2026-03-25 2026-03-25 0001498148 2026-04-20 0001498148 2026-04-20 2026-04-20 0001498148 2026-05-04 0001498148 2026-05-04 2026-05-04 0001498148 us-gaap:PreferredStockMember AITX:SeriesCConvertibleRedeemablePreferredStockMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2025-03-01 2025-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-02-28 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-03-01 2026-05-31 0001498148 AITX:SeriesFPreferredWarrantsMember 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-02-28 0001498148 AITX:CommonStockWarrantMember 2026-03-01 2026-05-31 0001498148 AITX:CommonStockWarrantMember 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-02-28 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-05-31 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-09 2021-03-10 0001498148 AITX:TenYearsLeaseAgreementMember 2021-03-10 0001498148 AITX:ThreeYearsLeaseAgreementMember 2024-02-04 2024-02-05 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-10 2025-03-11 0001498148 AITX:ThreeYearsLeaseAgreementMember 2025-03-11 0001498148 AITX:ConvertibleExchangeableDebtMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleExchangeableDebtMember 2025-03-01 2025-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2026-03-01 2026-05-31 0001498148 AITX:ConvertibleSeriesFPreferredSharesMember 2025-03-01 2025-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2026-03-01 2026-05-31 0001498148 us-gaap:SeriesCPreferredStockMember 2025-03-01 2025-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2026-03-01 2026-05-31 0001498148 us-gaap:EmployeeStockOptionMember 2025-03-01 2025-05-31 0001498148 us-gaap:SubsequentEventMember us-gaap:CommonStockMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:SharePurchaseAgreementMember 2026-06-01 2026-07-14 0001498148 us-gaap:SubsequentEventMember AITX:ExchangeAgreementsMember 2026-06-01 2026-07-14 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-03 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-03 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-09 2026-06-09 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember 2026-06-15 2026-06-15 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-06-15 2027-06-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-12-15 2026-12-15 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2027-07-15 2027-07-15 0001498148 us-gaap:SubsequentEventMember AITX:AmendedEquityFinancingAgreementMember 2026-06-23 2026-06-23 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 0001498148 AITX:PromissoryNotePayableMember AITX:LenderMember us-gaap:SubsequentEventMember 2026-06-26 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MinimumMember 2026-06-26 0001498148 AITX:PromissoryNotePayableOneMember AITX:LenderMember us-gaap:SubsequentEventMember srt:MaximumMember 2026-06-26 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 0001498148 AITX:LenderMember AITX:PromissoryNotePayableMember us-gaap:SubsequentEventMember 2026-07-09 2026-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AITX:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~NOVEMBER~~MAY 3031, ~~2025~~2026

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM _______________ TO _______________

COMMISSION FILE NUMBER: 000-55079

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Nevada		2740-~~2343603~~0018358
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification Number)
10800 Galaxie Avenue Ferndale, MI		48220
(Address of principal executive offices)		(Zip code)

(877) 787-6268

(Registrant’s telephone number, including area code)

not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☒

		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 25432,~~287~~030,~~280,437~~200 shares of common stock were issued and outstanding as of ~~January~~July 1213, 2026.

Table of Contents

		~~PAGE~~	PAGE
PART I	FINANCIAL INFORMATION
ITEM 1.	Financial Statements	3	3
	Condensed Consolidated Balance Sheets as of November 30, 2025 and February 28, 2025 (Unaudited)	3
	Condensed Consolidated Balance Sheets as of May 31, 2026 and February 28, 2026 (Unaudited)		3
	Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended November 30, 2025 and 2024 (Unaudited)	4
	Condensed Consolidated Statements of Operations for the Three Months Ended May 31, 2026 and 2025 (Unaudited)		4
	Condensed Consolidated Statements of Stockholders’ Deficit for the Nine Months Ended November 30, 2025 and 2024 (Unaudited)	5-6
	Condensed Consolidated Statements of Stockholders’ Deficit for the Three Months Ended May 31, 2026 and 2025 (Unaudited)		5
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended November 30, 2025 and 2024 (Unaudited)	7
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended May 31, 2026 and 2025 (Unaudited)		6
	Notes to the Consolidated Financial Statements (Unaudited)	~~8-27~~	7-28
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28	29
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	33	33
ITEM 4.	Controls and Procedures	33	33
PART II	OTHER INFORMATION
ITEM 1.	Legal Proceedings	34	34
ITEM 1A.	Risk Factors	34	34
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34	34
ITEM 3.	Defaults Upon Senior Securities	34	35
ITEM 4.	Mine Safety Disclosures	34	35
ITEM 5.	Other Information	34	35
ITEM 6.	Exhibits	35	35
SIGNATURES		36	36

-2-

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	November 30, 2025 (unaudited)			February 28, 2025*
ASSETS
Current assets:
Cash	$	143,801		$	865,975
Accounts receivable, net		1,306,020			1,367,331
Share proceeds receivable		—			418,669
Device parts inventory, net		1,138,333			1,583,726
Prepaid expenses and deposits		505,285			792,842
Total current assets		3,093,439			5,028,543
Operating lease asset		970,324			1,010,545
Revenue earning devices, net of accumulated depreciation of $3,756,281 and $2,292,172, respectively		5,195,308			4,539,180
Fixed assets, net of accumulated depreciation of $582,896 and $491,186, respectively		221,433			258,328
Trademarks		35,319			33,321
Investment at cost		100,000			100,000
Security deposit		15,880			15,880
Total assets	$	9,631,703		$	10,985,797
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses	$	3,211,067		$	2,121,871
Customer deposits		162,811			91,578
Current operating lease liability		245,173			197,349
Current portion of deferred variable payment obligation		2,837,536			1,901,258
Loan payable - related party		437,984			329,365
Deferred compensation for CEO		1,392,230			2,202,600
Current portion of loans payable, net of discount of $512,676 and $0		6,747,115			519,105
Current portion of accrued interest payable		2,083,352			213,555
Total current liabilities		17,117,268			7,576,681
Non-current operating lease liability		711,842			810,513
Loans payable, net of discount of $0 and $360,163, respectively		20,535,881			31,922,078
Deferred variable payment obligation		2,525,000			2,525,000
Incentive compensation plan payable		4,000,000			4,000,000
Accrued interest payable		13,444,645			13,680,453
Total liabilities		58,334,636			60,514,725
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at November 30, 2025 and February 28, 2025, respectively		—			—
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 667 and 306 shares issued and outstanding at November 30, 2025 and February 28, 2025, respectively		876,968			402,084
Convertible, Redeemable Preferred Stock, value		876,968			402,084
Commitments and Contingencies		-			-
Stockholders’ deficit:
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at November 30, 2025 and February 28, 2025, respectively		—			—
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at November 30, 2025 and February 28, 2025, respectively		—			—
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively		3,350			3,350
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively		2,513			2,513
Preferred Stock, value		2,513			2,513
Common Stock, $0.00001 par value; 27,500,000,000 shares authorized 23,287,834,008 and 14,412,453,768 shares issued, issuable and outstanding, respectively		232,878			144,125
Additional paid-in capital		115,170,827			106,316,844
Preferred stock to be issued		99,086			99,086
Accumulated deficit		(165,088,555	)		(156,496,930	)
Total stockholders’ deficit		(49,579,901	)		(49,931,012	)
Total liabilities and stockholders’ deficit	$	9,631,703		$	10,985,797

(UNAUDITED)

	May 31, 2026			February 28, 2026*
ASSETS
Current assets:
Cash	$	94,643		$	109,043
Accounts receivable, net		974,897			1,004,201
Device parts inventory, net		1,378,950			1,318,742
Prepaid expenses and deposits		556,737			503,017
Total current assets		3,005,227			2,935,003
Operating lease asset		891,922			931,814
Revenue earning devices, net of accumulated depreciation of $3,781,667 and $3,257,668, respectively		4,850,345			5,097,627
Fixed assets, net of accumulated depreciation of $562,268 and $540,426, respectively		176,943			183,185
Trademarks		36,157			35,319
Investment at cost		100,000			100,000
Security deposit		19,280			19,280
Total assets	$	9,079,874		$	9,302,228
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses	$	2,675,960		$	3,007,270
Customer deposits		127,520			147,326
Current operating lease liability		239,242			243,690
Current portion of deferred variable payment obligation		3,459,840			3,161,727
Loan payable - related party		331,946			461,633
Deferred compensation for CEO		1,990,751			1,811,856
Current portion of loans payable, net of discount of $871,697 and $635,774		26,897,629			8,848,140
Current portion of accrued interest payable		9,167,495			2,271,106
Total current liabilities		44,890,383			19,952,748
Non-current operating lease liability		643,129			676,694
Loans payable, net		7,953,001			24,188,380
Deferred variable payment obligation		2,525,000			2,525,000
Incentive compensation plan payable		5,500,000			5,500,000
Accrued interest payable		3,207,606			9,122,552
Total liabilities		64,719,119			61,965,374

Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly,$1,200 stated value, 5,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively		—			—
Series C Convertible, Redeemable Preferred Stock. $0.001 par value; $1,200 stated value, redeemable at 109.5%, 12% dividend, 1,000 shares authorized, 354 and 417 shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively		465,465			547,941
Convertible, Redeemable Preferred Stock, value		465,465			547,941

Commitments and Contingencies
Stockholders’ deficit:
Preferred Stock, undesignated; 15,534,000 shares authorized; no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively		—			—
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at May 31, 2026 and February 28, 2026, respectively		—			—
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively		3,350			3,350
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,513 shares issued and outstanding, respectively		2,513			2,513
Preferred Stock, value		2,513			2,513
Common Stock, $0.00001 par value; 12,000,000,000 shares authorized 388,482,589 and 267,872,804 shares issued, issuable and outstanding, respectively		3,885			2,679
Additional paid-in capital		120,717,508			117,803,027
Preferred stock to be issued		99,086			99,086
Accumulated deficit		(176,931,052	)		(171,121,742	)
Total stockholders’ deficit		(56,104,710	)		(53,211,087	)
Total liabilities and stockholders’ deficit	$	9,079,874		$	9,302,228

*	Derived from audited information

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

-3-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended November 30, 2025			Three Months Ended November 30, 2024			Nine Months Ended November 30, 2025			Nine Months Ended November 30, 2024
	Three Months Ended May 31, 2026			Three Months Ended May 31, 2025
Revenues	$	21,~~010~~831,~~158~~202		$	1,~~750~~854,~~968~~837		$	~~5,753,744~~		$	~~4,277,951~~
Cost of Goods Sold		202,441			289,339			426,485			688,024
Cost of goods sold		134,183			173,381
Depreciation and amortization		~~507~~513,~~265~~195			~~287~~447,~~799~~955			~~1,448,441~~			~~729,672~~
Total Cost of Goods Sold		~~709~~647,~~706~~378			~~577~~621,~~138~~336			~~1,874,926~~			~~1,417,696~~
Gross Profit		1,~~300~~183,~~452~~824			1,~~173~~233,~~830~~501			~~3,878,818~~			~~2,860,255~~
Operating expenses:
Research and development (Note 9)		1,096,970			579,045			3,104,303			1,897,165
Research and development (see Note 10)		885,593			1,087,619
General and administrative		2,~~737~~907,~~329~~577			23,~~733~~232,~~547~~211			~~8,604,371~~			~~8,220,564~~
Depreciation and amortization		3632,~~358~~646			~~106~~34,~~261~~121			~~107,379~~			~~309,699~~
Operating lease cost and rent		6167,~~295~~372			5758,~~875~~219			~~182,092~~			~~182,855~~
Total operating expenses		3,~~931~~893,~~952~~188			34,~~476~~412,~~728~~170			~~11,998,145~~			~~10,610,283~~
Loss from operations		(2,~~631~~709,~~500~~364	)		(23,~~302~~178,~~898~~669	)		~~(8,119,327~~	)		~~(7,750,028~~	)
Other income (expense), net:
Other expense, net:
Interest expense		(12,~~469~~298,~~300~~874	)		(1,~~401~~415,~~076~~349	)		~~(4,182,611~~	)		~~(4,072,108~~	)
Gain (loss) on settlement of debt		(630,000	)		—			3,740,185			(6,520	)
Loss on settlement of debt		(707,600	)		—
Total other income (expense), net		(2,099,300	)		(1,401,076	)		(442,426	)		(4,078,628	)
Total other expense, net		(3,006,474	)		(1,415,349	)
Net Loss	$	(4,730,800	)	$	(3,703,974	)	$	(8,561,753	)	$	(11,828,656	)
Net loss	$	(5,715,838	)	$	(4,594,018	)
Net income (loss) per share - basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss per share - basic	$	(0.02	)	$	(0.03	)
Net income (loss) per share - diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss per share - diluted	$	(0.02	)	$	(0.03	)
Weighted average common share outstanding - basic		21325,~~820~~956,~~801,041~~059			12155,~~161~~176,~~286,427~~712			~~18,590,935,695~~			~~11,071,139,695~~
Weighted average common share outstanding - diluted		21325,~~820~~956,~~801,041~~059			12155,~~161~~176,~~286,427~~712			~~18,590,935,695~~			~~11,071,139,695~~

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

-4-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Shares			Amount			Shares		Amount		Shares			Amount			Shares		Amount		Capital			Deficit			Deficit
	Temporary Equity						Shareholder’s Deficit
	Series B Preferred Stock						Series E Preferred Stock				Series F Preferred Stock						Common Stock				Additional Paid-In			Accumulated			Total Shareholders’
	Series C Preferred Stock						Series E Preferred Stock				Series F Preferred Stock						Common Stock				Additional Paid-In			Accumulated			Total Shareholders’
	Shares			Amount			Shares		Amount		Shares			Amount			Shares		Amount		Capital			Deficit			Deficit
Balance at February 29, 2024		—			—			3,350,000	$	3,350		2,533		$	101,619			9,238,750,958	$	92,388	$	92,565,513		$	(132,962,427	)	$	(40,199,557	)
Balance at February 28, 2025		306		$	402,084			3,350,000	$	3,350		2,513		$	101,599			144,124,538	$	1,441	$	106,459,528		$	(156,496,930	)	$	(49,931,012	)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024		—			—			—		—		—			—			—		—		—			(4,175,535	)		(4,175,535	)
Issuance of shares, net of $121,746 issuance costs		—			—			—		—		—			—			19,000,000		190		2,691,104			—			2,691,294
Issuance of shares, net of $116,046 issuance costs		—			—			—		—		—			—			1,080,166,425		10,802		2,671,791			—			2,682,593
Debt exchanged for common shares		—			—			—		—		—			—			6,850,000		69		1,250,431			—			1,250,500
Issuance of Series B Preferred Shares		300			360,000			—		—		—			—			—		—		(82,000	)		—			(82,000	)
Series C Preferred shares issued as dividend		9			12,073			—		—		—			—			—		—		(12,073	)		—			(12,073	)
Series B Preferred Shares issued as commitment fee		20			24,000			—		—		—			—			—		—		(24,000	)		—			(24,000	)
Stock based compensation		—			—			—		—		—			—			—		—		80,355			—			80,355
Series B Preferred shares issued as dividend		2			2,568			—		—		—			—			—		—		(2,568	)		—			(2,568	)
Net loss		—			—			—		—		—			—			—		—		—			(4,594,018	)		(4,594,018	)
Redemption of Series B Preferred shares		(107	)		(128,856	)		—		—		—			—			—		—		28,856			(28,856	)		—
Balance at May 31, 2025		315		$	414,157			3,350,000	$	3,350		2,513		$	101,599			169,974,538	$	1,700	$	110,469,345		$	(161,090,948	)	$	(50,514,954	)
Stock based compensation		—			—			—		—		—			—			—		—		83,323			—			83,323
Net income		—			—			—		—		—			—			—		—		—			(4,194,359	)		(4,194,359	)
Balance at May 31, 2024		215		$	257,712			3,350,000	$	3,350		2,533		$	101,619			10,318,917,383	$	103,190	$	95,240,915		$	(141,361,177	)	$	(45,912,103	)
Issuance of shares, net of $195,656 issuance costs		—			—			—		—		—			—			1,330,610,802		13,306		4,478,054			—			4,491,360
Debt exchanged for common stock		—			—			—		—		—			—			57,142,857		571		199,429			—			200,000
Series F Preferred Shares exchanged for debt		—			—			—		—		(20	)		(20	)		—		—		(65,793	)		(334,187	)		(400,000	)
Series B Preferred shares issued as dividend		2			2,620			—		—		—			—			—		—		(2,620	)		—			(2,620	)
Redemption of Series B Preferred shares		(217	)		(260,332	)		—		—		—			—			—		—		60,333			(60,333	)		—
Stock based compensation		—			—			—		—		—			—			—		—		83,323			—			83,323
Net income		—			—			—		—		—			—			—		—		—			(3,930,323	)		(3,930,323	)
Balance at August 31, 2024		—		$	—			3,350,000	$	3,350		2,513		$	101,599			11,706,671,042	$	117,067	$	99,993,641		$	(145,686,020	)	$	(45,470,363	)
Issuance of shares, net of $93,885 issuance costs		—			—			—		—		—			—			875,000,000		8,750		2,064,643			—			2,073,393
Stock based compensation		—			—			—		—		—			—			—		—		83,323			—			83,323
Net income		—			—			—		—		—			—			—		—		—			(3,703,974	)		(3,703,974	)
Balance at November 30, 2024		—		$	—			3,350,000	$	3,350		2,513		$	101,599			12,581,671,042	$	125,817	$	102,141,607		$	(149,389,994	)	$	(47,017,621	)

	Shares			Amount			Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Deficit
	Temporary Equity						Shareholder’s Deficit
	Series C Preferred Stock						Series E Preferred Stock				Series F Preferred Stock				Common Stock				Additional Paid-In			Accumulated			Total Shareholders’
	Shares			Amount			Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Deficit

Balance at February 28, 2026		417		$	547,941			3,350,000	$	3,350		2,513	$	101,599		267,872,804	$	2,679	$	117,803,027		$	(171,121,742	)	$	(53,211,087	)

Issuance of shares, net of $77,391 issuance costs		—			—			—		—		—		—		36,786,492		368		823,112			—			823,480
Debt exchanged for common shares		—			—			—		—		—		—		39,000,000		390		1,453,110			—			1,453,500
Commitment fee issuable		—			—			—		—		—		—		1,250,000		13		28,738			—			28,751
Commitment fee issued		—			—			—		—		—		—		5,000,000		50		173,450			—			173,500
Commitment fee returnable		—			—			—		—		—		—		14,100,000		141		(141	)		—			—
Redemption of Series C on conversion to common shares		(298	)		(391,572	)		—		—		—		—		24,473,250		244		484,800			(93,472	)		391,572
Issuance of Series C shares		222			291,708			—		—		—		—		—		—		(91,708	)		—			(91,708	)
Series C Preferred shares issued as dividend		13			17,388			—		—		—		—		—		—		(17,388	)		—			(17,388	)
Stock based compensation		—			—			—		—		—		—		—		—		60,508			—			60,508
Rounding shares		—			—			—		—		—		—		43		—		—			—			—
Net loss		—			—			—		—		—		—		—		—		—			(5,715,838	)		(5,715,838	)
Balance at May 31, 2026		354		$	465,465			3,350,000	$	3,350		2,513	$	101,599		388,482,589	$	3,885	$	120,717,508		$	(176,931,052	)	$	(56,104,710	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

-5-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Temporary Equity						Shareholder’s Deficit
	Series B & C Preferred Stock						Series E Preferred Stock				Series F Preferred Stock				Common Stock				Additional Paid-In			Accumulated			Total Shareholders’
	Shares			Amount			Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Deficit
Balance at February 28, 2025		306		$	402,084			3,350,000	$	3,350		2,513	$	101,599		14,412,453,768	$	144,125	$	106,316,844		$	(156,496,930	)	$	(49,931,012	)
Issuance of shares, net of $121,746 issuance costs		—			—			—		—		—		—		1,900,000,000		19,000		2,672,294			—			2,691,294
Debt exchanged for common shares		—			—			—		—		—		—		685,000,000		6,850		1,243,650			—			1,250,500
Series C Preferred shares issued as dividend		9			12,073			—		—		—		—		—		—		(12,073	)		—			(12,073	)
Stock based compensation		—			—			—		—		—		—		—		—		80,355			—			80,355
Net income		—			—			—		—		—		—		—		—		—			(4,594,018	)		(4,594,018	)
Balance at May 31, 2025		315		$	414,157			3,350,000	$	3,350		2,513	$	101,599		16,997,453,768	$	169,975	$	110,301,070		$	(161,090,948	)	$	(50,514,954	)
Issuance of shares, net of $75,919 issuance costs		—			—			—		—		—		—		1,540,380,240		15,403		1,236,983			—			1,252,386
Debt exchanged for common shares		—			—			—		—		—		—		1,250,000,000		12,500		1,237,500			—			1,250,000
Series C Preferred shares issued as dividend		9			12,435			—		—		—		—		—		—		(12,435	)		—			(12,435	)
Series C penalty shares		114			149,307			—		—		—		—		—		—		(149,307	)		—			(149,307	)
Redemption of Series C shares		(95	)		(125,000	)		—		—		—		—		—		—		29,871			(29,871	)		—
Stock based compensation		—			—			—		—		—		—		—		—		80,355			—			80,355
Net income		—			—			—		—		—		—		—		—		—			763,064			763,064
Balance at August 31, 2025		343		$	450,899			3,350,000	$	3,350		2,513	$	101,599		19,787,834,008	$	197,878	$	112,724,037		$	(160,357,755	)	$	(47,330,891	)
Balance		343		$	450,899			3,350,000	$	3,350		2,513	$	101,599		19,787,834,008	$	197,878	$	112,724,037		$	(160,357,755	)	$	(47,330,891	)
Issuance of shares, net of $166,496 issuance costs		—			—			—		—		—		—		1,600,000,000		16,000		841,504			—			857,504
Issuance of shares, net of issuance costs		—			—			—		—		—		—		1,600,000,000		16,000		841,504			—			857,504
Debt exchanged for common shares		—			—			—		—		—		—		1,900,000,000		19,000		1,951,000			—			1,970,000
Series C Preferred shares issued as dividend		10			13,539			—		—		—		—		—		—		(13,539	)		—			(13,539	)
Series C penalty shares		314			412,530			—		—		—		—		—		—		(412,530	)		—			(412,530	)
Stock based compensation		—			—			—		—		—		—		—		—		80,355			—			80,355
Net income		—			—			—		—		—		—		—		—		—			(4,730,800	)		(4,730,800	)
Balance at November 30, 2025		667		$	876,968			3,350,000	$	3,350		2,513	$	101,599		23,287,834,008	$	232,878	$	115,170,827		$	(165,088,555	)	$	(49,579,901	)
Balance		667		$	876,968			3,350,000	$	3,350		2,513	$	101,599		23,287,834,008	$	232,878	$	115,170,827		$	(165,088,555	)	$	(49,579,901	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

-6-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended November 30, 2025			Nine Months Ended November 30, 2024
	Three Months Ended May 31, 2026			Three Months Ended May 31, 2025
CASH FLOWS USED IN OPERATING ACTIVITIES:
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(85,~~561~~715,~~753~~838	)	$	(114,~~828~~594,~~656~~018	)
Adjustments to reconcile net income to net cash used in operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1545,~~555,817~~841			1482,~~039,371~~076
Bad debts expense		~~141~~70,~~482~~000			3748,~~995~~982
Inventory provision		—			~~150,000~~—
Reduction of right of use asset		~~104~~38,~~585~~013			9133,~~152~~865
Accretion of lease liability		7923,~~294~~281			9027,~~165~~428
Stock based compensation		~~241~~60,~~065~~508			~~249~~80,~~969~~355
Amortization of debt discounts		~~301~~385,~~615~~493			~~198~~47,~~696~~089
Penalty added to face value of loan		16,560			—
Loss on settlement of debt		707,600			—
(Gain) loss on settlement of debt		(3,740,185	)		6,520
Increase (decrease) in related party accrued payroll and interest		(129,687	)		5,700
Increase in related party accrued payroll and interest		108,619			39,976
Changes in operating assets and liabilities:
Accounts receivable		(8040,~~171~~696	)		~~(531~~424,~~703~~655	)
Prepaid expenses		290,118			199,972
Prepaid expenses and deposits on inventory		(51,841	)		104,498
Deposit on right of use asset		~~(13,187~~—	)		—(13,187	)
Device parts inventory		(1336,~~718,797~~925	)		(2480,~~778,439~~951	)
Accounts payable and accrued expenses		1(332,~~084,168~~150	)		~~700~~524,~~082~~109
Deferred compensation for CEO		(810,370	)		(195,000	)
Customer deposits		(19,806	)		(487	)
Customer deposits		71,233			28,619
Operating lease liability payments		(60,449	)		(58,962	)
Operating lease liabilities		(178,849	)		(171,898	)
Deferred compensation for CFO		178,895			(1,246,687	)
Current portion of deferred variable payment obligation for payments		936,278			695,594
Current portion of deferred variable payment obligations for payments		298,112			301,287
Accrued interest payable		21,~~721~~620,~~315~~342			3993,~~083,301~~063
Net cash used in operating activities		(72,~~451~~759,~~163~~307	)		(83,~~894~~321,~~284~~185	)
CASH FLOWS USED IN INVESTING ACTIVITIES:
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets		(1015,~~863~~600	)		(238,~~724~~422	)
Acquisition of trademarks		(~~1,998~~838	)		(41,~~144~~298	)
Convertible note receivable		—			(50,000	)
Net cash (used in) investing activities		(16,438	)		(9,720	)
Net cash used in investing activities		(12,861	)		(77,868	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs		5823,~~219,853~~480			82,~~894~~839,~~645~~777
Proceeds from loans payable		2,375,671			350,000
Proceeds on issuance of Series C shares		200,000			—
Repayment of loans payable		(728,674	)		(183,000	)
Proceeds from loans payable		2,714,028			—
Proceeds on issuance of Series B Preferred shares		—			278,000
Repayment of loans payable		(976,163	)		(50,000	)
Redemption of Series B or Series C Preferred shares		(125,000	)		(389,188	)
Net cash provided by financing activities		2,761,345			2,789,777
Net cash provided by financing activities		6,741,850			8,950,457
Net change in cash		(14,400	)		(541,128	)
Net change in cash		(722,174	)		(21,695	)
Cash, beginning of period		109,043			865,975
Cash, beginning of period		865,975			105,926
Cash, end of period	$	94,643		$	324,847
Cash, end of period	$	143,801		$	84,231
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	$	9719,~~979~~257		$	818,~~040~~910
Cash paid for income taxes	$	—		$	—
Noncash investing and financing activities:
Share proceeds receivable	$	418,669		$	352,701
Transfer from device parts inventory to fixed assets and revenue earning devices	$	276,717		$	917,294
Transfer from device parts inventory to revenue earning devices	$	2,164,190		$	2,876,508
Exchange of notes payable and accrued interest for common shares	$	745,900		$	1,250,500
Right of use asset for lease liability	$	53,739		$	—
Discount applied to face value of loan	$	419,167		$	—
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024	$	—		$	4,175,535
Conversion of Series C shares to common shares	$	391,572		$	—
Exchange of Series F preferred stock for note payable	$	—		$	400,000
Series C preferred shares issued as dividend	$	17,388		$	12,073
Exchange of note payable for common stock	$	3,840,590		$	200,000
Commitment fee shares as debt discount	$	202,050		$	—
Series B or Series C preferred shares issued as dividend	$	38,047		$	5,188
Right of use asset for lease liability	$	—		$	53,739
Discount applied to face value of loans	$	454,129		$	—
Series C penalty shares issued	$	561,837		$	—

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

-76-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. GENERAL INFORMATION

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

2. GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

For the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, the Company had negative cash flow from operating activities of $72,~~451~~759,~~163~~307. As of ~~November~~May 3031, ~~2025,~~ 2026, the Company has an accumulated deficit of $~~165~~176,~~088~~931,~~555~~052, and negative working capital of $1441,~~023~~885,~~829~~156. Management does not anticipate ~~having~~ having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

The Company does not have the resources atcurrently ~~this time~~ to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

Management is committed to ~~raise~~raising ~~either non-dilutive~~ funds ~~or minimally dilutive funds~~. There is no assurance that ~~these~~management ~~funds~~ will be able to ~~be raised,~~raise funds nor can we provide assurance that these possible raises may not have dilutive effects. InOn June ~~2025~~23, 2026, the Company entered into an equity financing agreement whereby an investor will purchase up to $3010,000,000 of the Company’s common stock at a discount over a ~~two~~three-year period. There still remains ~~about~~ $2710 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing ~~non-convertible~~ debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

-87-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

3. ACCOUNTING POLICIES

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on ~~May~~June 299, ~~2025~~2026. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices ~~Lanka~~Residential, ~~Pvt Limited~~Inc., and Robotic Assistance Devices ~~Residential,~~Lanka ~~Inc~~(Private) Limited.. All significant ~~intercompany~~ intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, are not necessarily indicative of the results that may be expected for the entire year.

Use of Estimates

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value ~~preferred~~equity ~~stock~~instruments ~~and~~used ~~derivative~~in ~~liabilities~~debt settlements, amendments and extensions.

Reclassifications

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

Concentrations

Loans payable

At ~~November~~May 3031, ~~2025~~2026 there were $2735,~~795~~722,~~672~~326 of loans payable, $2632,~~801~~466,~~006~~506 or 9691% of these loans to companies controlled by one individual. At At February 28, ~~2025~~2026 there were $3233,~~801~~672,~~345~~294 loans payable, $2832,~~581~~178,506 or 8796% of these loans to companies controlled by one individual.

Cash

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

Accounts Receivable

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $~~175~~240,000 and $~~140~~170,000 provided as of ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, respectively. For the three months ending ~~ended~~May ~~November 30~~31, ~~2025~~2026, ~~one~~two ~~customer~~customers ~~accounted~~account for 3923% of total accounts receivable. For the three months ~~ended~~ending ~~November~~May 3031, ~~2024~~2025, ~~one customer~~three ~~accounted~~customers account for 6153% of total accounts receivable.

Device Parts Inventory

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, there was a valuation reserve of $~~465~~175,000 and $~~465~~175,000, respectively.

-98-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Revenue Earning Devices

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures ~~impairment~~ impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

Fixed Assets

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

SCHEDULE OF FIXED ASSETS STATED AT COST

Computer equipment and software		2 or 3 years
Office equipment		4 years
Manufacturing equipment		7 years
Warehouse equipment		5 years
Tooling		2 years
Demo Devices		4 years
Vehicles		3 years
Leasehold improvements		5 years, the life of the lease

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

Research and Development

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At ~~November~~May 3031, ~~2025~~2026 and February 28, ~~2025~~2026, the Company had no deferred development costs.

Contingencies

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

Sales of Future Revenues

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

-109-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

● Does the agreement purport, in substance, to be a sale ● Does the Company have continuing involvement in the generation of cash flows due to the investor ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets ● Is the investors rate of return is implicitly limited by the terms of the agreement ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return ● Does the investor have recourse relating to payments due

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

Revenue Recognition

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, ~~one~~two ~~customer~~customers accounted for 5736% of total revenue and for the ~~nine~~three months ended ~~November~~May 3031, ~~2024~~2025, ~~one~~two ~~customer accounted~~customers accounted for 5765% of total revenue.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, ~~2026~~2027, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

Leases

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

-1110-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

Distinguishing Liabilities from Equity

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

Initial Measurement

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

Subsequent Measurement – Financial Instruments Classified as Liabilities

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:-11-

-12-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

	●	Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

	●	Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	●	Level 3 – Inputs that are unobservable for the asset or liability.

Measured on a Recurring Basis

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

	Amount at		Fair Value Measurement Using
	Fair Value		Level 1		Level 2		Level 3
November 30, 2025
May 31, 2026
Assets
Investment at cost	$	100,000	$	50,000	$	—	$	50,000
Liabilities
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares	$	45,~~000~~500,000	$	—	$	—	$	45,~~000~~500,000
February 28, 2025
February 28, 2026
Assets
Investment at cost	$	100,000	$	50,000	$	—	$	50,000
Liabilities
Incentive compensation plan payable – revaluation of equity awards payable in Series G shares	$	45,~~000~~500,000	$	—	$	—	$	45,~~000~~500,000

For the incentive compensation plan ~~(revaluation of equity awards payable in Series G shares)~~ referred to above , the Company recorded stock based compensation of $0 and $0 for the three months ended May ~~November 30~~31, ~~2025~~2026 and ~~February~~May 2831, 2025 with corresponding adjustments to incentive compensation plan payable.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

Earnings (Loss) per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

~~-13-~~Recently Adopted Accounting Pronouncements

ASU 2023-07 – Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments require enhanced disclosures about significant segment expenses and other segment items, require disclosure of the title and position of the chief operating decision maker (“CODM”), explain how the CODM uses reported measures of segment profit or loss to assess performance and allocate resources, and expand interim disclosure requirements. The amendments apply to entities with a single reportable segment as well as entities with multiple reportable segments.

-12-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, during fiscal 2025. The standard requires enhanced disclosures regarding segment expenses and CODM information and applies to entities with a single reportable segment. Adoption of the standard impacted the Company’s segment reporting disclosures only and did not affect its consolidated financial position, results of operations, or cash flows.

Recently issued accounting pronouncement not yet effective

ASU 2024-04—Debt with Conversion and Other Options (Topic 470-20): Induced Conversions of Convertible Debt Instruments

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or as debt extinguishments. Under the amended guidance, an induced conversion requires that the inducement offer provide the holder, at a minimum, the consideration issuable under the existing conversion privileges of the instrument.

The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim reporting periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements and related disclosures.

ASU 2025-05—Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments refine the guidance in ASC 326 related to the measurement of expected credit losses for accounts receivable and contract assets arising from revenue transactions accounted for under ASC 606. The update clarifies the application of the current expected credit loss (“CECL”) model to such assets, including the use of practical expedients and considerations in estimating expected credit losses over the contractual term of the asset.

The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-05 on its consolidated financial statements and related disclosures.

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

The following table presents revenues from contracts with customers disaggregated by product/service:

Three Months Ended November 30, 2025

Three Months Ended November 30, 2024

Nine Months Ended November 30, 2025

Nine Months Ended November 30, 2024

Three Months Ended May 31, 2026

Three Months Ended May 31, 2025

Device rental activities

1,~~807~~613,~~083~~095

1,~~429~~627,~~112~~286

~~5,129,840~~

~~3,475,546~~

Direct sales of goods and services

~~203~~218,~~075~~107

~~321~~227,~~856~~551

~~623,904~~

~~802,405~~

Revenue

21,~~010~~831,~~158~~202

1,~~750~~854,~~968~~837

~~5,753,744~~

~~4,277,951~~

-1413-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

5. LEASES

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

Below is a summary of our lease assets and liabilities at ~~November~~May 3031, ~~2025~~2026 and February 28, ~~2025~~2026.

Leases	Classification	~~November~~May 3031, ~~2025~~2026		February 28, ~~2025~~2026
Assets
Operating	Operating Lease Assets	$	~~970~~891,~~324~~922	$	1931,~~010,545~~814
Liabilities
Current
Operating	Current Operating Lease Liability	$	~~245~~239,~~173~~242	$	~~197~~243,~~349~~690
Noncurrent
Operating	Noncurrent Operating Lease Liabilities		~~711~~643,~~842~~129		~~810~~676,~~513~~694
Total lease liabilities		$	~~957~~882,~~015~~371	$	1920,~~007,862~~384

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

~~Rent~~Operating ~~expense and operating~~ lease cost and rent was $6167,~~295~~372 and $~~182~~58,~~092~~219 for the three ~~and nine~~ months ended ~~November~~May 3031, ~~2025,~~2026 ~~respectively,~~ and ~~$57,875 and~~May ~~$182~~31,~~855~~ ~~for the three and nine months ended November 30~~2025, ~~2024,~~ respectively.

6. INVESTMENT

On December 23, 2022 the Company entered into a Simple Agreement for Future Equity (SAFE) contract to invest $50,000 to acquire shares of a company’s capital stock at a discount. On June 3, 2024 the Company acquired a $50,000 convertible note receivable from Nightingale Intelligent Systems, Inc., a private Delaware corporation that provides unmanned aerial vehicles (UAV) for commercial applications. On January 3, 2025 the Company exchanged it’s convertible note receivable for : 1,770,840 Series A preferred shares, 15,000 common shares and 165,000 common share warrants. On February 28, 2025, there was a 10 :1 split. The Company now holds 177,084 Series A preferred shares, 1,500 common shares and 16,500 common share warrants (at a strike price of $0.80/share). The Company values the Nightingale Intelligent Systems, Inc.’s shares and warrants at $50,000 bringing total investments at cost to $100,000 at ~~November~~May 3031, ~~2025~~2026 and February 28, 2026.

7. REVENUE EARNING DEVICES

Revenue earning devices consisted of the following:

SCHEDULE OF REVENUE EARNING DEVICES

	November 30, 2025			February 28, 2025
	May 31, 2026			February 28, 2026
Revenue earning devices	$	8,~~951~~632,~~589~~012		$	68,~~831~~355,~~352~~295
Less: Accumulated depreciation		(3,~~756~~781,~~281~~667	)		(23,~~292~~257,~~172~~668	)
Total	$	54,~~195~~850,~~308~~345		$	45,~~539~~097,~~180~~627

During the three ~~and nine~~ months ended ~~November~~May 3031, ~~2025~~2026, the Company made total additions to revenue earning devices of $~~359~~276,~~974~~717 ~~and $2,120,237 respectively,~~ which were transfers from inventory. During the three ~~and nine~~ months ended ~~November~~May 3031, ~~2024~~2025, the Company made total additions to revenue earning devices of $1895,~~069,822~~547 ~~and $2,800,355, respectively,~~ which were transfers from inventory.

Depreciation and amortization for the ~~three~~years ~~and nine months~~ ended ~~November~~May 3031, ~~2025~~2026, and ~~2024~~May 31, 2025, are as follows:

Depreciation and Amortization	Three Months Ended November 30, 2025		Three Months Ended November 30, 2024		Nine Months Ended November 30, 2025		Nine Months Ended November 30, 2024
Depreciation and Amortization RED	Three Months Ended May 31 2026		Three Months Ended May 31, 2025
Cost of Goods Sold	$	~~507~~513,~~265~~195	$	~~287~~447,~~799~~955	$	~~1,448,441~~	$	~~729,672~~
Operating expenses		510,~~831~~804		794,~~662~~104		~~15,671~~		~~198,935~~
Total Depreciation and Amortization	$	513,096	$	367,461	$	1,464,112	$	928,607
Total Depreciation and Amortization RED	$	523,999	$	452,059

-1514-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

8. FIXED ASSETS

Fixed assets consisted of the following:

SCHEDULE OF FIXED ASSETS

	November 30, 2025			February 28, 2025
	May 31, 2026			February 28, 2026
Automobile	$	74,237		$	74,237
Demo devices		~~346~~265,~~139~~421			~~302~~265,~~186~~421
Tooling		~~107~~122,~~020~~620			107,020
Machinery and equipment		17,246			817,~~825~~246
Computer equipment		157,448			157,448
Office equipment		15,312			15,312
Furniture and fixtures		21,225			21,225
Warehouse equipment		38,746			3638,~~305~~746
Leasehold improvements		26,956			26,956
Fixed assets gross		~~804~~739,~~329~~211			~~749~~723,~~514~~611
Less: Accumulated depreciation		(~~582~~562,~~896~~268	)		(~~491~~540,~~186~~426	)
Fixed assets, net of accumulated depreciation	$	~~221~~176,~~433~~943		$	~~258~~183,~~328~~185

During the three months ~~ended~~ending ~~November~~May 3031, ~~2025~~2026, the Company made additions of $1415,~~309 of which $11,868 were transfers from inventory with remaining additions of $2,441~~600. During the ~~nine~~three months ~~ended~~ending ~~November~~May 3031, 2025, the Company ~~made additions of $54,816 of which $43,953 were transfers~~ ~~from inventory with remaining additions of $10,863. During the three months ended November 30, 2024, the Company~~ made additions of $2546,~~603, all~~071 of which ~~were transfers from inventory. During the nine months ended November 30, 2024, the Company made additions of~~ $9922,~~877~~347 ~~of which $76,153~~ were transfers from inventory with remaining additions of $23,724.

Depreciation and amortization for the ~~three~~years ~~and nine months~~ ended ~~November~~May 3031, ~~2025~~2026, and ~~2024~~May 31, 2025, are as follows:

Depreciation and Amortization

Three Months Ended ~~November~~May ~~30,~~31 ~~2025~~2026

Three Months Ended ~~November~~May 3031, ~~2024~~2025

~~Nine Months Ended November 30, 2025~~

~~Nine Months Ended November 30, 2024~~

Fixed assets

3021,~~527~~842

2630,~~599~~017

~~91,708~~

~~110,764~~

Revenue earning devices

510,~~831~~804

794,~~662~~104

~~15,671~~

~~198,935~~

Total Depreciation and Amortization included in operating expenses

3632,~~358~~646

~~106~~34,~~261~~121

~~107,379~~

~~309,699~~

9. DEFERRED VARIABLE PAYMENT OBLIGATION

On February 1, 2019, the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

On May 9, 2019, the Company entered into two similar arrangements with two investors:

	(1)	The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.

	(2)	The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

~~-16-~~In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

-15-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019, for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021, as a result of the amendment with the first investor noted below., ~~This~~this aggregate asset disposition % was reduced from 43.77 % to 33.77%.

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019, and accrue every quarter thereafter. As of ~~November~~May 3031, ~~2025~~2026, the Company has accrued $23,~~837~~459,~~536~~840 in Payments of which $12,~~599~~202,~~972~~545 are in arrears. As of February 28, ~~2025~~2026, the Company has accrued approximately $13,~~901~~161,~~258~~727 in Payments, of which $~~904~~1,~~377~~901,259 is in arrears. No notices have been received by the Company. The Company has recorded cumulative interest of 6% interest totaling $204,427 commencing this quarter, on the balance in arrears, and will continue to adjust quarterly.

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

	1)	The rate payment was reduced from 14.25 % to 9.65 %
	2)	The asset disposition % (see below) was reduced from 31 % to 21%

-1716-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five5-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

For both the three months ~~and nine months~~ ended ~~November~~May 3031, ~~2025~~2026, and year ended February 28, ~~2025~~2026, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both ~~November 30~~May 31, ~~2025~~2026 and February 28, ~~2025~~ 2026.

10. RELATED PARTY TRANSACTIONS

For both the three months ~~and nine months~~ ended ~~November~~May 3031, ~~2025~~2026, and ~~November~~May 3031, ~~2024~~2025, the Company had no repayments of net advances ~~from its~~of ~~loan~~$129,687 ~~payable-related~~and ~~party.~~$0, respectively. At ~~November~~May 3031, ~~2025~~2026, the loan payable-related party was $~~437~~331,~~984~~946 and $~~329~~461,~~635~~633 at February 28, ~~2025~~2026. Included in the balance due to the related party at ~~November~~May 3031, ~~2025~~2026, is $~~361~~255,~~452~~414 of deferred salary and interest, $~~239~~157,~~600~~513 of which bears interest at 12%. As of February 28, ~~2025~~2026, included in the balance due to the related party is $~~252~~285,~~833~~638 of deferred salary ~~and~~all ~~interest, $190,013~~ of which bears interest at 12%. The accrued interest included in the loan at ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, was $7084,~~689~~956, and $5179,~~575~~268, respectively.

During the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, the Company paid out gross payments to the CEO of $171,~~560,370~~ 105 offset by a bonus accrual of $~~750~~250,000, which yields a net change of $~~810~~178,~~370~~ 895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, ~~2025~~2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,~~392~~990,~~230~~ 751 and $21,~~202~~811,~~600~~ 856 at ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, respectively

For the three ~~and nine~~ months ended ~~November~~May 3031, ~~2025~~2026, the Company accrued $0 (three ~~and nine~~ months ended ~~November~~May 3031, ~~2024~~2025-$0) of incentive compensation plan payable to the CEO. This ~~would~~will be payable in Series G Preferred Shares, which are redeemable at the Company’s option at $1,000 per share. On AtMay ~~November 30~~31, ~~2025~~2026, and February 28, ~~2025~~2026, there was $45,~~000~~500,000 and $45,~~000~~500,000 of incentive compensation payable.

During the three months ended ~~November~~May 3031, ~~2025~~2026, and ~~2024~~2025, the Company was charged $~~655~~390,~~721~~130 and $~~556~~736,~~175~~875, respectively for fees for research ~~and~~ and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company, and the fees were spent on core development projects. As at May 31, 2026, and February 28, 2026, the balance due to this company was $76,532 and $160,557, respectively.

During the nine months ended November 30, 2025, and 2024, the Company was charged $1,990,873 and $1,846,005, respectively for fees for research and development from a company partially owned by a principal shareholder. The principal shareholder received no compensation from this partially owned research and development company and the fees were spent on core development projects. As at both November 30, 2025, and February 28, 2025, the balance due to this company was $76,532.-17-

-18-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

11. LOANS PAYABLE

Loans payable at ~~November~~May 3031, ~~2025~~2026 consisted of the following:

SCHEDULE OF LOANS PAYABLE

Date	Maturity	Description		Principal	~~Principal~~			Interest Rate	~~Interest Rate~~
July 18, 2016	July 18, 2017	Promissory note (1)*	(1)*	$	$3,500	~~3,500~~			22	22%	%
December 10, 2020	March 1, 2027	Promissory note (2)	~~(2)~~		3,921,168	~~3,921,168~~			A12	12%	%
December 10, 2020	March 1, 2027	Promissory note (3)	~~(3)~~		2,754,338	~~2,754,338~~			A12	12%	%
December 10, 2020	December 10, 2024	Promissory note	(4)*			182,165				12	%
December 14, 2020	March 1, 2027	Promissory note (5)			310,375				12	%
December 14, 2020	March 1, 2027	Promissory note	(5)			310,375				12	%
December 30, 2020	March 1, 2027	Promissory note (6)			350,000				A 12	%
December 30, 2020	March 1, 2027	Promissory note	(6)			350,000				12	%
January 1, 2021	March 1, 2027	Promissory note (7)			25,000				12	%
January 1, 2021	March 1, 2027	Promissory note (8)	~~(7)~~		145,000	~~25,000~~			12	12%	%
January 1, 2021	March 1, 2027	Promissory note	(8)			145,000				12	%
January 14, 2021	March 1, 2027	Promissory note (9)			237,500				A 12	%
January 14, 2021	March 1, 2027	Promissory note	(9)			-				12	%
February 22, 2021	March 1, 2027	Promissory note (10)			1,650,000				12	%
February 22, 2021	March 1, 2027	Promissory note	(10)			1,650,000				12	%
March 1, 2021	March 1, 2027	Promissory note (11)			6,000,000				12	%
March 1, 2021	March 1, 2027	Promissory note	(11)			2,585,000				12	%
June 8, 2021	June 8, 2027	Promissory note (12)			2,750,000				12	%
June 8, 2021	June 8, 2027	Promissory note	(12)			2,750,000				12	%
September 14, 2021	September 14, 2027	Promissory note (14)			1,650,000				A 12	%
July 12, 2021	July 26, 2026	Promissory note	(13)			-				7	%
July 28, 2022	March 1, 2027	Promissory note (15)			170,000				15	%
September 14, 2021	September 14, 2027	Promissory note	(14)			1,650,000				12	%
August 30, 2022	August 30,2027	Promissory note (16)			3,000,000				A 15	%
July 28, 2022	March 1, 2027	Promissory note	(15)			170,000				15	%
September 7, 2022	March 1, 2027	Promissory note (17)			400,000				15	%
August 30, 2022	August 30,2027	Promissory note	(16)			3,000,000				15	%
September 8, 2022	March 1, 2027	Promissory note (18)			475,000				15	%
September 7, 2022	March 1, 2027	Promissory note	(17)			400,000				15	%
October 13, 2022	March 1, 2027	Promissory note (19)			350,000				15	%
September 8, 2022	March 1, 2027	Promissory note	(18)			475,000				15	%
October 28, 2022	October 31, 2026	Promissory note (20)			293,000				A 15	%
October 13, 2022	March 1, 2027	Promissory note	(19)			350,000				15	%
November 9, 2022	October 31, 2026	Promissory note (20)			400,000				A 15	%
October 28, 2022	October 31, 2026	Promissory note	(20)			400,000				15	%
November 10, 2022	October 31, 2026	Promissory note (20)			400,000				A 15	%
November 9, 2022	October 31, 2026	Promissory note	(20)			400,000				15	%
November 15, 2022	October 31, 2026	Promissory note (20)			400,000				A 15	%
November 10, 2022	October 31, 2026	Promissory note	(20)			400,000				15	%
January 11, 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
November 15, 2022	October 31, 2026	Promissory note	(20)			400,000				15	%
February 6, 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
January 11, 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
April 5. 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
February 6, 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
April 20, 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
April 5. 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
May 11, 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
April 20, 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
October 27, 2023	October 31, 2026	Promissory note (20)			400,000				A 15	%
May 11, 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
November 30, 2023	April 30, 2027	Purchase Agreement (21)			203,000				15	%
October 27, 2023	October 31, 2026	Promissory note	(20)			400,000				15	%
March 8, 2024	August 8, 2027	Purchase Agreement (22)			350,000				15	%
November 30, 2023	April 30, 2026	Purchase Agreement	(21)			203,000				15	%
July 26, 2025	July 26, 2026	Promissory note (23)			165,000				C 15	%
March 8, 2024	August 8, 2025	Purchase Agreement	(22)*			350,000				15	%
August 7,2025	August 7,2026	Promissory note (24)			245,000				C 15	%
July 26, 2025	July 26, 2026	Promissory note	(23)			165,000				15	%
August 25, 2025	August 25, 2026	Promissory note (25)			137,500				C 15	%
August 7,2025	August 7,2026	Promissory note	(24)			245,000				15	%
August 25, 2025	May 6, 2026	Future Receivables Purchase and Sale Agreement (26)			—				108	%
August 25, 2025	August 25, 2026	Promissory note	(25)			137,500				15	%
September 25, 2025	September 25, 2026	Promissory note (27)			550,000				C 15	%
August 25, 2025	May 6, 2026	Future Receivables Purchase and Sale Agreement	(26)			498,626				108	%
October 30. 2025	October 30. 2026	Promissory note (28)			200,000				C 15	%
September 25, 2025	September 25, 2026	Promissory note	(27)			550,000				15	%
November 6, 2025	November 6, 2026	Promissory note (29)			275,000				C 15	%
October 30. 2025	October 30. 2026	Promissory note	(28)			200,000				15	%
November 24, 2025	November 24, 2026	Promissory note (30)			450,000				C 15	%
November 6, 2025	November 6, 2026	Promissory note	(29)			275,000				15	%
December 9, 2025	December 9, 2026	Promissory note (31)			450,000				C 15	%
November 24, 2025	November 24, 2026	Promissory note	(30)			450,000				15	%
December 17, 2025	September 23, 2026	Business loan (32)			—				65	%
					$	27,795,672
December 22, 2025	December 22, 2026	Convertible note (33)			495,000				12	%
Less: current portion of loans payable						(7,259,791	)
December 27, 2025	December 27, 2026	Promissory note (34)			275,000				C 15	%
Less: discount on non-current loans payable						-
January 12, 2026	January 12, 2027	Promissory note (35)			330,000				C 15	%
Non-current loans payable, net of discount					$	20,535,881
January 27, 2026	January 27, 2027	Promissory note (36)			170,000				C15	%
Current portion of loans payable					$	7,259,791
February 2, 2026	February 2, 2027	Promissory note (37)			330,000				C15	%
Less: discount on current portion of loans payable						(512,676	)
February 19, 2026	February 19, 2027	Convertible note (38)			165,000				12	%
Current portion of loans payable, net of discount					$	6,747,115
February 24, 2026	February 24, 2027	Promissory note (39)			170,000				C15	%
March 16, 2026	March 16, 2027	Promissory note (13)			170,000				C15	%
March 25, 2026	March 25, 2027	Convertible note (40)			110,000				12	%
March 25, 2026	March 25, 2026	Convertible note (41)			—				12	%
April 9, 2026	January 15, 2027	Convertible note (42)			257,000				10	%
April 13, 2026	April 13, 2027	Future Receivables Purchase and Sale Agreement (43)			641,279				NA
April 20, 2026	April 20, 2027	Convertible note (44)			277,778				12	%
May 1, 2026	January 15, 2027	Convertible note (45)			157,000				10	%
May 4, 2026	May 4, 2027	Convertible Note (46)			700,000				12	%
May 28 2026	May 28 2026	Convertible Note (47)			138,889				12	%
May 29, 2026	May 29, 2027	Promissory note (4)			225,000				C15	%
				$	35,722,327
Less: current portion of loans payable					(27,769,326	)
Less: discount on non-current loans payable					-
Non-current loans payable, net of discount				$	7,953,001
Current portion of loans payable				$	27,769,326
Less: discount on current portion of loans payable					(871,697	)
Current portion of loans payable, net of discount				$	26,897,629

*	In default

On June 15, 2026 the Company and lender entered into a Loan Amendment Agreement whereby it was agreed that simple interest was to be calculated from the loan issuance date through to February 28, 2026 and commencing March 1, 2026 compounded on the respective principal and interest balance at February 28, 2026.

^C	Compounding annually

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.

-18-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On December 10, 2025 an exchange agreement was made whereby principal and interest of this note may be exchanged for common shares at 90% of the 5 days’ lowest bid of shares. For the three months ending May 31, 2026 the company exchanged $336,000 accrued interest for 14,000,000 common shares at a fair value of $910,700 with a loss on settlement of $574,700.

(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. On February 8, 2026, the holder exchanged $192,000 in accrued interest for 8,000,000 common shares at fair value of $320,000 with a loss on settlement of $128,000.

(4)	Original $225,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $115, with an unamortized discount of $24,885 at May 31, 2026.

(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. On December 14, 2023, the parties extended the maturity date from December 14, 2023 date to March 1, 2027.

(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized.

(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. Through an exchange agreement on February 11, 2025, the Company repaid $162,000 in principal st through the issuance of 600,000 common shares. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. On March 5, 2025 the Company repaid $150,500 in loan principal as well as $275,000 in accrued interest (all totaling $425,500) was repaid on March 5, 2025 through the issuance of 1,850,000 common shares at a fair value of $444,000 with a loss on settlement of $18,500.

-19-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. The loan is fully amortized. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the three months ending May 31, 2026, the Company exchanged $80,000 of accrued interest for 5,000,000 common at a fair value of $100,000 with a loss on settlement of $20,000.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. On March 28, 2025 the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest VWAP price. For the year ended February 28, 2026, the Company has issued 36,500,000 common shares at fair market value of $4,365,500 to repay $3,840,500 in accrued interest with a loss on settlement of debt of $525,000.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. The loan is fully amortized. On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of price the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. For the year ended February 28, 2026 the holder exchanged $1,416,000 in accrued interest for 25,000,000 common shares at a fair value of $1,680,000 with a loss on settlement of $264,000.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. The note is in default. No notices have been sent.
(13)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $3,680, with an unamortized discount of $16,320 at May 31, 2026.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,455, with an unamortized discount of $13,870 at May 31, 2026. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the nine months ended November 30, 2025, the Company recorded amortization expense of $138, with an unamortized discount of $0 at November 30, 2025.The loan is fully amortized.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of the note into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

-20-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024, to March 1, 2025, with all other terms and Conditions remaining the same. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the nine months ended November 30, 2025, the Company recorded amortization expense of $144, with an unamortized discount of $0 at November 30, 2025.The loan is fully amortized. On February 11, 2025, the Company repaid $162,000 through the issuance of 60,000,000 common shares. The remaining $388,000 in loan principal as well as $35,500 in accrued interest ( all totaling $425,500) was repaid on March 5, 2025 through the issuance of 185,000,000 common shares.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022, to February 22, 2024, on February 28, 2022, in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024, to March 1, 2025, with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the nine months ended November 30, 2025, the Company recorded amortization expense of $700, with an unamortized discount of $0 at November 30, 2025. The loan is fully amortized.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same. For the nine months ended November 30, 2025, the Company has issued 3,835,000,000 common shares at fair market value of $4,470,500 to repay $3,840,500 in loan principal with a loss on settlement of debt of $630,000.
(20)	On October 28, 2022, the Company entered into as secured loan agreement with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 24, 2025, the Company entered into an exchange agreement where the holder can exchange all or part of the principal and interest of this secured loan agreement into common shares at an exchange amount of 90% of the previous 5 day’s lowest bid price. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the six months ended August 31, 2025, the Company recorded amortization expense of $964, with an unamortized discount of $0 at August 31, 2025. The loan is fully amortized On April 16, 2025, the parties again extended the maturity date from June 8, 2025, to June 8, 2027, with all other terms and conditions remaining the same.
	October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,243, with an unamortized discount of $9,185 at May 31, 2026.For the three months ending May 31, 2026, the Company exchanged $107,000 of principal and $222,900 of accrued interest totaling $329,900 for 20,000,000 common at a fair value of $442,800 with a loss on settlement of $112,900.
	November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of 9,233 at May 31, 2026.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $8,957at May 31, 2026.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,528, with an unamortized discount of $8,927 at May 31, 2026.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,269, with an unamortized discount of $9,233 at May 31, 2026.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,288, with an unamortized discount of $9,268 at May 31, 2026.

-21-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. During the six months ended August 31, 2025 the Company repaid $420,000 as part of a settlement with the estate of the lender. A settlement agreement was entered into on April 25,2025 between the Company and the Estate of the lender whereby the Company will repay a total of $420,000 to fully discharge the outstanding loan balance and accrued interest which totaled $4,790,185. This settlement agreement was approved by the court on June 5, 2025. Upon settlement in August 2025, the Company recorded a gain on settlement of debt of $4,370,185. At August 31, 2025 the outstanding principal and interest was $0.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $6,476, with an unamortized discount of $18,705 at November 30, 2025. On April 16, 2025, the parties again extended the maturity date from September 14, 2025, to September 14, 2027, with all other terms and conditions remaining the same.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. On April 16, 2025, the parties again extended the maturity date from August 30, 2025, to August 30, 2027, with all other terms and conditions remaining the same.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,302, with an unamortized discount of $9,293 at May 31, 2026.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,343, with an unamortized discount of $9,368 at May 31, 2026.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained For the three months ended May 31, 2026, the Company recorded amortization expense of $5,480, with an unamortized discount of $9,616 at May 31, 2026.

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,325, with an unamortized discount of $9,333 at May 31, 2026.

(21)	On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same. On April 30,2026, the parties extended the maturity to April 30, 2027, with the default rate still applicable after April 30, 2025.

(22)	On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after original maturity. The August 2024 through to August 2025 payments have not been made and the note was not repaid at original maturity. On August 8, 2025 the parties extended the maturity to August 8, 2027 , with the default rate still applicable after August 8, 2025.

(23)	Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.

(24)	Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.

(25)	Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.

(26)	On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the year ended May 31, 2026, the Company recorded amortization expense of $59,207, with an unamortized discount of $0 at May 31, 2026. For the year ended February 28, 2026, the Company has repaid $617,348. During the three months ending May 31, 2026 the remaining balance of $ 189,952 was fully repaid.

(27)	Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $12,724, with an unamortized discount of $17,288 at May 31, 2026.

(28)	Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,158, with an unamortized discount of $11,127 at May 31, 2026.

(29)	Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $6,189, with an unamortized discount of $11,582 at May 31, 2026.

(30)	Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,760, with an unamortized discount of $28,536 at May 31, 2026.

-22-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023, to March 1, 2025, with all other terms and conditions remaining the same. This note has been fully amortized. On April 16, 2025, the parties again extended the maturity date from March 1, 2025, to March 1, 2027, with all other terms and conditions remaining the same.
(31)	Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $11,888, with an unamortized discount of $27,702 at May 31, 2026.
(20)	On October 28, 2022, the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
(32)	On December 17, 2025, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $300,000 after fees of $14,000 and a financing fee of $91,060 for total fees of $105,060. The Company must repay $405,060, in 4 weekly payments of $2,276.50 and 36 weekly payments of $10,998.72. The loan is personally guaranteed by the CEO. For the year ended February 28, 2026, the Company recorded amortization expense of $19,478 with an unamortized discount of $85,582 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $87,990 with the balance of $241,972 transferred to the April 13, 2026 loan described in footnote (43),thereby fully extinguishing this loan.
	October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,502, with an unamortized discount of $19,409 at November 30, 2025.
(33)	$495,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $440,000, with fees of $10,000 and an original issue discount of $45,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $13,062, with an unamortized discount of $32,233 at May 31, 2026. . After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
	November 9, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,567, with an unamortized discount of $19,508 at November 30, 2025.
(34)	Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,908, with an unamortized discount of $14,970 at May 31, 2026.
(35)	Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,019, with an unamortized discount of $19,117 at May 31, 2026.
(36)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,594, with an unamortized discount of $13,637 at May 31, 2026.
(37)	Original $330,000 note may be pre-payable at any time. The note balance includes an original issue discount of $30,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,059, with an unamortized discount of $21,078 at May 31, 2026.
(38)	$165,000 convertible note that may be redeemed at a premium at any time. The Company received proceeds of $142,500, with fees of $7,500 and an original issue discount of $15,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $5,167, with an unamortized discount of $16,849 at May 31, 2026. After 180 days , the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.
(39)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three months ended May 31, 2026, the Company recorded amortization expense of $4,555, with an unamortized discount of $15,257 at May 31, 2026.
(40)	$110,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $95,000, with fees of $5,000 and an original issue discount of $10,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $2,429, with an unamortized discount of $12,571 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 80% of the lowest traded price in the 15 prior trading days.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,613, with an unamortized discount of $23,671 at November 30, 2025.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,525, with an unamortized discount of $19,446 at November 30, 2025.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,567, with an unamortized discount of $19,508 at November 30, 2025.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,614, with an unamortized discount of $19,581 at November 30, 2025.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,647, with an unamortized discount of $19,630 at November 30, 2025.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,749, with an unamortized discount of $19,786 at November 30, 2025.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $14,085, with an unamortized discount of $20,299 at November 30, 2025.

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with six a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the nine months ended November 30, 2025, the Company recorded amortization expense of $13,703, with an unamortized discount of $19,715 at November 30, 2025.

-23-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(21)	On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after maturity. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed April through to August 2024 payments in agreement with the lender. The Company have missed the subsequent monthly payments. On April 16, 2025, the parties again extended the maturity date from April 30, 2025, to April 30, 2026, with all other terms and conditions remaining the same.
(41)	$630,000 convertible note that may be redeemed subject to a premium ranging from 110% to 140% if redeemed within the first 180 days of the note. The Company received proceeds of $595,000, with fees of $5,000 and an original issue discount of $30,000. Principal and interest due at maturity. A refundable commitment fee of 14.1 million common shares was issued, but is returnable if the loan plus accrued interest is paid back by May 5, 2026. The loan was intended as a short term loan with high redemption premiums commencing after 40 days and high conversion discounts after 180 days whereby the note would convert at 20% of the lowest traded price 15 days prior trading to the conversion date. On May 5, 2026, the Company repaid in full, principal and interest of $638,492 and the 14.1 million commitment fee shares will be returned.. For the three months ended May 31, 2026, the Company recorded amortization expense of $35,000, with an unamortized discount of $0 at May 31, 2026.
(22)	On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 8, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment and after maturity. The August 2024 through to August 2025 payments have not been made but will be resolved with the lender and the note was not repaid at maturity. The Company believes it will re-negotiate the maturity date with the lender as it has done with similar loans. No notices have been sent.
(42)	$257,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $250,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
(23)	Original $165,000 note may be pre-payable at any time. The note balance includes an original issue discount of $15,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
(43)	On April 13, 2026, the Company entered into a business loan secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $295,028 after fees of $16,500 and a financing fee of $91,060 for total fees of $105,060 and a payback of the $241,972 balance on the December 17, loan described in footnote (32) . The Company must repay $709,500, in 52 weekly payments of $13,644. The loan is personally guaranteed by the CEO. For the three months ended May 31, 2026, the Company recorded amortization expense of $16,587 with an unamortized discount of $155,913 at February 28, 2026. For the three months ended May 31, 2026, the Company has repaid $68,221.
(24)	Original $245,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
(44)	$277,778 convertible note that may be redeemed anytime with payment of the first year’s accrued interest of $33,333. The Company received proceeds of $245,000, with fees of $5,000 and an original issue discount of $27,778. In addition a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and added as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $10,072, with an unamortized discount of $196,206 at May 31, 2026. The note and interest is convertible at any time a conversion price of 75% of the lowest closing traded price in the 10 prior trading days.
(25)	Original $137,500 note may be pre-payable at any time. The note balance includes an original issue discount of $12,500. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. The discount was expensed.
(45)	$157,000 convertible note that may be redeemed subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The Company received proceeds of $150,000, with fees of $7,000. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,000, with an unamortized discount of $0 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest closing traded price in the 10 prior trading days.
(26)	On August 25, 2025, the Company entered into Future Receivables Purchase and Sale Agreement secured by a general security charging all of RAD’s present and after- acquired property. The Company received net proceeds of $555,671 after fees of $29,329 and a financing fee of $222,300 for total fees of $251,629. The Company must repay $807,300, in weekly payments of 7% of estimated receipts from accounts receivables. The estimated monthly payments will be approximately $99,725. For the nine months ended November 30, 2025, the Company recorded amortization expense of $96,211, with an unamortized discount of $155,418 at November 30, 2025. For the nine months ended November 30, 2025, the Company has repaid $308,674.
(46)	$700,000 convertible note redeemable 90 days after issuance in monthly installments of 10% of the outstanding principal and interest. The Company received proceeds of $615,000, with fees of $15,000 and an original issue discount of $70,000. In addition a commitment fee of 1,250,000 common shares having a fair value of $28,751 was issued and recorded as a discount. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $7,185, with an unamortized discount of $105,565 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.
(27)	Original $550,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended November 30, 2025, the Company recorded amortization expense of $8,031, with an unamortized discount of $41,969 at November 30, 2025.
(28)	Original $200,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended November 30, 2025, the Company recorded amortization expense of $1,935, with an unamortized discount of $23,065 at November 30, 2025.
(29)	Original $275,000 note may be pre-payable at any time. The note balance includes an original issue discount of $25,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended November 30, 2025, the Company recorded amortization expense of $1,412, with an unamortized discount of 23,588 at November 30, 2025.
(30)	Original $450,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the nine months ended November 30, 2025, the Company recorded amortization expense of $622, with an unamortized discount of 49,378 at November 30, 2025.

(47)

$138,889 convertible note that may be redeemed subject to a premium ranging from 110% to 135% if redeemed within the first 180 days of the note. The Company received proceeds of $119,000, with fees of $6,000 and an original issue discount of $13,889.. Principal and interest due at maturity. For the three months ended May 31, 2026, the Company recorded amortization expense of $762, with an unamortized discount of $19,127 at May 31, 2026. After 180 days, the note and interest is convertible at a conversion price of 65% of the lowest traded price in the 10 prior trading days.

-24-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

12. STOCKHOLDERS’ EQUITY (DEFICIT)

Summary or Preferred Stock Activity

Series C Convertible, Redeemable Preferred Stock (Temporary Equity)

On February 10, 2025, in connection with a Share Purchase Agreement the Company created a new class of Series C Convertible Redeemable with 1,000 authorized shares.

In exchange for 306 Series C Convertible Redeemable Preferred Shares (“Series C”), the Company received gross proceeds of $306,000 with net proceeds of $278,580 after paying $6,000 in legal fees and $21,420 in broker fees both charged against paid in capital. The Company must redeem the shares at stated capital of 1,200 per share and a 1.09095 premium at 180 days after issuance~~, On August 9~~.~~2025.~~ The Company recorded the 306 outstanding shares at its redemption value of $402,084 at February 28, 2025, with the offsetting adjustment to paid in capital. On ~~May~~During ~~10,~~the ~~2025~~year the Company issued ~~the~~ 12% quarterly ~~dividend~~dividends in ~~9.19~~ 44 Series C shares with a ~~redemption~~ value of $1258,~~073~~100. The OnCompany ~~August~~failed ~~9, 2025~~to redeem the ~~Company~~Series ~~issued~~C shares on the ~~12%~~August ~~quarterly~~9, ~~dividend~~2025, inredemption ~~9.46~~date and a penalty of 114 Series C shares with a ~~redemption~~ value of $12149,~~436~~307 was recorded. OnIn August 9, 2025 the Company ~~recorded~~redeemed 95 Series C shares for $125,000 including a ~~35%~~deemed ~~penalty~~dividend ~~due~~of to$29,871. In ~~not~~September ~~redeeming~~2025 the ~~shares~~Company atfailed ~~the~~to ~~redemption~~convert ~~date~~a conversion notice of 96 shares. ~~The~~This ~~penalty~~conversion ~~amounted~~was towithdrawn ~~114~~in December 2025 and a new conversion for 85 Series C shares at with a value of $~~149~~111,~~307.~~690 including Ona ~~August~~dividend 25of $84,690 with ~~2025~~a ~~the~~corresponding ~~Company~~adjustment ~~redeemed~~to 95paid in capital. In exchange for the converted Series C shares, ~~for~~the ~~$125~~Company issued 1,~~000~~994,464 common shares. ~~Included~~In inJanuary ~~that~~2026, ~~payment~~the ~~was~~Company failed to convert a ~~deemed~~conversion ~~dividend~~ notice of ~~$28,871~~80 shares. On ~~November~~March 719, ~~2025~~2026 the Company ~~issued~~entered into an agreement with the ~~12%~~investor ~~quarterly~~whereby ~~dividend~~the inparties ~~10.3~~agreed to reduce the penalty on the September 2025 and January 2026 failed conversion to 133 Series C shares ~~with~~at a ~~redemption~~ value of $13175,~~539.~~140 ( The ~~Company~~penalty ~~recorded~~was areduced ~~penalty~~from ~~for~~345 Series ~~not~~C ~~converting~~shares 96to 133 Series C shares) . The parties agreed on the Series C share balance at February 28, 2026 to be 417 series C shares. In addition, the parties agreed to issue an additional 222 Series C shares for proceeds of $200,000 and fees of $22,000. These shares have a redemption value of $~~115~~291,~~200~~708. Also on ~~September~~March 2219, ~~2025.~~2026, ~~The~~the ~~penalty~~parties ~~was~~agreed ~~recorded~~to ~~as additional~~convert ~~314~~ 165 Series C ~~preferred~~ shares at a value of $~~412~~216,~~530~~810 for ~~with~~13,550,625 common ashares. ~~corresponding~~The ~~adjustment~~shareholder toalso ~~paid~~converted in40 shares ~~capital.~~at ~~The~~a ~~September~~value 22of $52,560 ~~2025~~for ~~conversion~~3,285,000 common ~~was~~shares ~~rescinded~~ on ~~December~~May 56, ~~2025~~2026, and a93 shares ~~new~~at ~~conversion~~a ~~was~~value ~~done~~of $122,202 for 847,637,628 common ~~series~~shares Con ~~shares~~May ~~for~~12, ~~199~~2026. During the quarter,~~446,429~~ ~~common~~a ~~shares~~dividend of 13 atSeries C shares having a value of $~~100,800~~ ~~on December 5~~$17,388 were ~~2025~~accrued. At ~~November~~May 3031, ~~2025~~2026, ~~2025~~ there were ~~667~~ 354 outstanding series C shares with a redemption value of $~~876~~465,~~968~~465. Ay At February 28, ~~2025~~2026, there were ~~306~~ 417 outstanding series C shares with a redemption value of $~~402~~547,~~084~~941.

Series F Convertible Preferred ~~Shares~~Stock

Each holder of Series F Convertible Preferred Shares may, at any time and from time to time convert all, but not less than all, of their shares into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45) on a pro rata basis.

Summary of Preferred Stock Warrant Activity

	Number of Series F Preferred Warrants		Weighted Average Exercise Price		Weighted Average Remaining Years
Outstanding at February 28, 2025		939	$	1.00		8.5
Outstanding at February 28, 2026		939	$	1.00		7.5
Issued		—		—		—
Exercised		—		—		—
Forfeited and cancelled		—		—		—
Outstanding at November 30, 2025		939	$	1.00		8.25
Outstanding at May 31, 2026		939	$	1.00		7.25

-2425-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Summary of Common Stock Activity

~~The~~For ~~Company’s~~the ~~board~~three ofmonths ~~directors~~ended ~~voted~~May ~~to increase authorized common shares from 23~~31,~~000,000,000~~ ~~to 27,500,000,000 on October 15, 2025.~~2026:

~~For~~- The Company decreased authorized common shares from ~~the~~27,500,000,000 ~~nine~~to ~~months~~12,000,000,000 ~~ended~~on ~~November~~March 3019, ~~2025:~~2026.

- ~~the~~ ~~Company~~On ~~issued~~February 5,~~040~~ 2026,~~380,240~~ ~~common~~the ~~shares~~holders ~~with~~of ~~gross~~a ~~proceeds~~majority of the voting power of ~~$5,165,385~~the ~~and~~Company’s ~~net~~outstanding ~~proceeds~~voting ofsecurities ~~$4,801,184~~executed ~~after~~the ~~issuance~~written ~~costs~~consent approving a reverse stock split of ~~$364~~the Company’s issued and outstanding Common Stock at a ratio of 1-for-100. This split was deemed effective on March 12,~~161~~ 2026. The common shares have been adjusted to reflect this reverse stock split.

- the Company issued 336,~~835~~784,~~000,000~~492 common shares towith ~~repay~~gross proceeds of $3900,~~840,500~~871 inand ~~loans~~net ~~payable~~proceeds ~~and~~of $37823,~~500~~480 inafter ~~accrued~~issuance ~~interest~~costs ~~all~~of ~~totaling~~ $377,~~803,000~~391.

- the Company issued 39,000,000 common shares having a fair value of $1,453,500 to repay $107,000 in loans payable and $638,900 in accrued interest totaling $745,900 with a loss on settlement of debt of $707,600.

-Along with the $630,000 loan of March 25, 2026, a refundable commitment fee of 14,100,000 shares was issued. These shares are refundable if the loan was fully repaid by May 5, 2026, and it was. The shares were recorded at par value of $141 with a corresponding adjustment to paid in capital.

-Along with the $277,778 loan of April 20, 2026, a commitment fee of 5,000,000 common shares having a fair value of $173,500 was issued and recorded as a discount.

-Along with the $700,000 loan of May 4, 2026, a commitment fee of 1,250,000 common shares having a fair value of $28,751 is issuable and recorded as a discount. These shares will be issued shortly after filing this 10Q.

-During the quarter ended March 31, 2026, the Series C Preferred shareholder converted 298 Series C Preferred Shares having a value of $391,572 for 24,473,250 common shares with a deemed dividend of $93,472.

The common shares issued , issuable and outstanding at May 31,2026 and February 28, 2026:

Common shares	May 31, 2026		February 28, 2026
Issued		387,232,589		267,872,804
Issuable		1,250,000		-

Issued, issuable and outstanding		388,482,589		267,872,804

Summary of Common Stock Warrant Activity

For the three months ~~and~~ending ~~nine~~May ~~months~~31, ~~ended November 30~~2026, ~~2025~~ and ~~November~~May 3031, ~~2024~~2025, the Company recorded a total of $8060,~~355~~508 and $8380,~~323, and~~355 ~~$241,065 and $249,969~~ respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Years
Outstanding at February 28, 2025		47,271,449	$	0.003		2.44
Outstanding at February 28, 2026		470,000	$	0.04		1.44
Issued		—		—		—
Exercised		—		—		—
Forfeited and cancelled		—		—		—
Outstanding at November 30, 2025		47,271,449	$	0.001		1.68
Outstanding at May 31, 2026		470,000	$	0.02		1.19

~~Summary of Common Stock Option Activity~~ -~~Employee Stock Options~~26-

SUMMARY OF COMMON STOCK OPTION ACTIVITY

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Years
Outstanding at March 1, 2025		182,228,131		$	0.02		3.10
Issued		—			—		—
Exercised		—			—		—
Forfeited, extinguished and cancelled		(3,322,058	)	$	0.02		(2.99	)
Outstanding at November 30, 2025		178,906,073		$	0.02		2.35

-25-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Summary of Common Stock Option Activity -Employee Stock Options

SUMMARY OF COMMON STOCK OPTION ACTIVITY

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Years
Outstanding at March 1, 2026		1,732,121	$	2.00		2.10
Issued		—		—		—
Exercised		—		—		—
Forfeited, extinguished and cancelled		—	$	—		—
Outstanding at May 31, 2026		1,732,121	$	2.00		1.85

13. COMMITMENTS AND CONTINGENCIES

Litigation

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

The related legal costs are expensed as incurred.

On September 24, 2024, a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. The Company and its counsel believe the claim is without merit however the courts have mandated mediation. After consideration of business factors the parties executed a settlement agreement in June 2025 with the Company agreeing to pay $65,000 with no admission of wrongdoing. The Company paid the $65,000 on August 1, 2025.

Operating Lease

On March 10, 2021, the Company entered into a 10 year lease agreement for a manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

On March 11, 2025, the Company entered into a 3-year lease agreement for a vehicle commencing March 11, 2025 through to March 11, 2028 with a minimum base rent of $1,286 per month. The Company paid a down payment of $13,188. The Company recorded the right of use asset of $5367,~~739~~372 with a corresponding adjustment to operating lease liability.

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. ~~Rent~~The ~~expense~~weighted ~~and~~average ~~operating~~discount ~~lease~~rate ~~cost~~used was ~~$61,295~~10% and ~~$182,092 for~~ the ~~three~~weighted ~~and~~average ~~nine~~remaining ~~months~~lease ~~ended~~term ~~November 30,~~at ~~2025,~~May ~~respectively~~31, ~~and~~2026 was ~~$57,875~~4.71 ~~and $182,855 for the three and nine months ended November 30, 2024 respectively~~years.

~~Summary~~Rent ~~of rent~~ expense and operating lease cost ~~are~~was ~~recorded~~$67,372 ~~over~~and $58,219 for the ~~lease~~three ~~terms~~months onended aMay ~~straight-line~~31, ~~basis~~2026 and May 31, 2025, respectively.

Maturity of Lease Liabilities	Operating Leases
November 30, 2026	$	245,173
May 31, 2027	$	239,243
November 30, 2027		230,348
May 31, 2028		222,427
November 30, 2028		212,514
May 31, 2029		207,558
November 30, 2029		207,558
May 31, 2030		207,558
November 30, 2030		207,558
May 31, 2031		190,261
November 30, 2031 and after		86,482
Total lease payments		1,067,047
Total lease payments		1,189,633
Less: Interest		(184,676	)
Less: Interest		(232,618	)
Present value of lease liabilities	$	882,371
Present value of lease liabilities	$	957,015

~~-26-~~14. EARNINGS (LOSS) PER SHARE

The net income (loss) per common share amounts were determined as follows:

	May 31, 2026			May 31, 2025
	For the Three Months Ended
	May 31, 2026			May 31, 2025
Numerator:
Net loss available to common shareholders	$	(5,715,838	)	$	(4,594,018	)

Effect of common stock equivalents
Less: dividends to C preferred shareholders		(110,860	)		(12,073	)
Net loss adjusted for common stock equivalents		(5,826,698	)		(4,606,091	)

Denominator:
Weighted average shares – basic		325,956,059			155,176,712

Net loss per share – basic	$	(0.02	)	$	(0.03	)

Denominator:
Weighted average shares – diluted		325,956,059			155,176,712

Net loss per share – diluted	$	(0.02	)	$	(0.03	)

-27-

Table of Contents

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

~~14.~~The ~~EARNINGS~~anti-dilutive ~~(LOSS)~~shares ~~PER~~of ~~SHARE~~common stock equivalents for the three months ended May 31, 2026 and 2025 were as follows:

The net income (loss) per common share amounts were determined as follows:

SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE

	2025			2024			2025			2024
	For the Three Months Ended						For the Nine Months Ended
	November 30,						November 30,
	2025			2024			2025			2024
Numerator:
Net income (loss) available to common shareholders	$	(4,730,800	)	$	(3,703,974	)	$	(8,561,753	)	$	(11,828,656	)
Effect of common stock equivalents
Deduct : Dividend on Series B shares		—			—			(29,871	)		(89,189	)
Deduct: Deemed dividend on redemption of Series F shares		—			—			—			(334,187	)
Net income (loss) adjusted for common stock equivalents		(4,730,800	)		(3,703,974	)		(8,591,624	)		(12,252,032	)
Denominator:
Weighted average shares – basic		21,820,801,041			12,161,286,427			18,590,935,695			11,071,139,695
Net income (loss) per share – basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Dilutive effect of common stock equivalents:
Convertible Debt		—			—			—			—
Preferred shares		—			—			—			—
Warrants		—			—			—			—
Total		—			—			—			—
Denominator:
Weighted average shares – diluted		21,820,801,041			12,161,286,427			18,590,935,695			11,071,139,695
Net income (loss) per share – diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2024 and 2023 were as follows:

	2025		2024		2025		2024
	May 31, 2026		May 31, 2025
	For the Three Months Ended				~~For the Nine Months Ended~~
	November 30,				November 30,
	May 31, 2026		May 31, 2025
	2025		2024		2025		2024
Convertible or exchangeable debt		3,173,350,733		-
Convertible Series F Preferred Shares*		80,343,027,328		43,406,765,095		80,343,027,328		43,406,765,095
Convertible Series F Preferred Shares		1,340,264,933		586,412,155
Series C Preferred Shares		1,218,011,111		—		1,218,011,111		—
Convertible Redeemable Series C Preferred Shares		30,948,471		2,958,264
Stock options and warrants		~~226~~2,~~177~~202,~~522~~121		~~232~~2,~~927~~261,~~455~~775		~~226,177,522~~		~~232,927,455~~
Total		814,~~787~~546,~~215~~766,~~961~~258		43591,~~639~~632,~~692,550~~194		~~81,787,215,961~~		~~43,639,692,550~~

15. SUBSEQUENT EVENTS

Subsequent to ~~November~~May 3031, ~~2025:~~2026 through to filing date,

— the Company issued 32,797,611 common shares pursuant to a share purchase agreement for gross proceeds of $290,783, issuance costs of $14,397 and net proceeds of $276,386. — The Company issued 112,000,000 shares to a lender to settle $89,700 in principal pursuant to exchange agreements with the lender. — on June 3, 2026, the Company issued a convertible, redeemable note to a lender for $230,000 with cash proceeds of $200,000 an original issue discount of $23,000 and $7,000 for fees. The loan bears interest at 6%, the note is redeemable by the Company at any time subject to a premium ranging from 105% to 140% if redeemed within the first 180 days of the note. The note matures on June 3, 2027, and converts after 180 days at 65% of the lowest trading price 20 trading days prior to the conversion date, including the conversion date. — on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $55,000 with cash proceeds of $47,500, an original issue discount of $5,000, and $2,500 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $5,500. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date. — on June 9, 2026, the Company issued a convertible, redeemable note to a lender for $110,000 with cash proceeds of $95,000, an original issue discount of $10,000, and $5,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium of one years interest of $11,000. The note matures on June 9, 2027, and converts any time at 65% of the lowest trading price 10 trading days prior to the conversion date. — on June 15, 2026, the Company issued a convertible, redeemable note to a lender for $165,000 with cash proceeds of $142,800, an original issue discount of $15,000, and $7,200 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 115% to 125% if redeemed within the first 180 days of the note. The note matures on June 15, 2027, and converts any time at 65% of the lowest closing bid price 20 trading days prior to the conversion date. The loan is repayable as follows : on December 15, 2026 a payment of $90,750 with 5 monthly payments of $15,125 commencing Jan 15, 2027 through to May 15, 2027 with the remaining $9,625 balance payable June 15, 2027. — on June 23 , 2026 the Company entered into an Equity Financing Agreement whereby an investor shall invest up to $10,000,000 over the course of thirty-six (36) month at a purchase price of eighty-five percent (85%) of the average of the three lowest bid trade price in the 10 day preceding period. The Company may also issue an accelerated put at a purchase price of 85% of the three closing bid prices 10 days following the put date subject to a floor price equal to the greater of: (A) seventy-five percent (75%) of the Closing Bid Price of the Common Stock on the applicable Put Date; or (B) any higher minimum price per share specified by the Company in the applicable Accelerated Put Notice. A commitment fee of five million common shares of the Company’s Common Stock shall be issued in two equal tranches: (i) first tranche of Two Million and Five Hundred Thousand common shares upon S-1 effectiveness; and the remaining (ii) second tranche of Two Million and Five Hundred Thousand common shares, issued ninety days later. In conjunction with the above agreement, the Company entered into a Registration Rights Agreement as well. — on June 26, 2026, the Company issued a convertible, redeemable note to ~~repay~~a lender for $1157,~~080~~000 with cash proceeds of $150,000 and $7,000 for fees. The loan bears interest at 10%, the note is redeemable by the Company at any time subject to a premium ranging from 120% to 125% if redeemed within the first 180 days of the note. The note matures on March 30, 2027, and converts after 180 days at 65% of the average of the three lowest trading prices, 10 trading days prior to the conversion date. — on July 9, 2026, the Company issued a promissory note to a lender for $165,000 with cash proceeds of $150,000 and an original issue discount of $15,000 for fees. The note matures in ~~loans~~one ~~payable~~year and bears interest at 15%, per annum ,compounding annually. The note is secured by the assets of the Company.

~~— On December 5, 2025 the Series C preferred shareholder converted 84 series C shares for 199,446,429 common shares at a value of $100,800.~~-28-

— On December 9, 2025 the Company issued a promissory note to a lender for $450,000 with cash proceeds of $400,000 and an original issue discount of $50,000. The loan bears interest at 15%, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

— On December 17, 2025 the Company issued a promissory note to a lender for $275,000 with cash proceeds of $250,000 and an original issue discount of $25,000. The loan bears interest at 15%, matures in 1 year and has a general security charging all of the Company’s present and after-acquired property.

— On December 22, 2025 the Company issued a convertible, redeemable note to a lender for $495,000 with cash proceeds of $450,000 and an original issue discount of $45,000. The loan bears interest at 12%, the note is redeemable by the Company at any time subject to a premium, matures in 1 year and converts at 80% of the lowest trading price 15 trading days prior to the conversion date including the conversion date. Interest is payable in common shares at either the redemption date or maturity.

-27-

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following discussion of our financial condition and results of operations for the three ~~and nine~~ months ended ~~November~~May 3031, ~~2025~~2026 and ~~November 30~~May 31, ~~2024~~2025 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 28, ~~2025~~2026, as filed on ~~May~~June 299, ~~2025~~2026 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

Overview

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

A short list of basic examples include:

	1.	Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.

	2.	Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.

	3.	Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

RAD solutions are unique because they:

	1.	Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.

	2.	Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.

	3.	Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

-2829-

Table of Contents

Management Discussion and Analysis

Results of Operations for the Three Months Ended ~~November~~May 3031, ~~2025,~~2026 and ~~2024~~2025

The following table shows our results of operations for the three months ended ~~November~~May 3031, ~~2025,~~2026 and ~~2024~~2025. The historical results presented ~~below~~ below are not necessarily indicative of the results that may be expected for any future period.

	Period						~~Change~~
	Three Months Ended November 30, 2025			Three Months Ended November 30, 2024			Dollars			Percentage
	Three Months Ended			Three Months Ended			Change
Revenues	$	2,010,158		$	1,750,968		$	259,190			15	%
	May 31, 2026			May 31, 2025			Dollars			Percentage
Gross profit		1,300,452			1,173,830			126,622			11	%
Revenues	$	1,831,202		$	1,854,837		$	(23,635	)		(1	)%
Operating expenses		3,931,952			3,476,728			455,224			13	%
Gross profit		1,183,824			1,233,501			(49,677	)		(4	)%
Loss from operations		(2,631,500	)		(2,302,898	)		(328,602	)		(14	)%
Operating expenses		3,893,188			4,412,170			(518,982	)		(12	)%
Other income (expense), net		(2,099,300	)		(1,401,076	)		(698,224	)		(50	)%
Loss from operations		(2,709,364	)		(3,178,669	)		469,305			15	%
Net loss	$	(4,730,800	)	$	(3,703,974	)	$	(1,026,826	)		(28	)%
Other expense, net		(3,006,474	)		(1,415,349	)		(1,591,125	)		(112	)%
Net loss	$	(5,715,838	)	$	(4,594,018	)	$	(1,121,820	)		(24	)%

Revenue

The following table presents revenues from contracts with customers disaggregated by product/service:

	Three Months Ended November 30,		Three Months Ended November 30,		Change
	Three Months Ended		Three Months Ended		Change
	2025		2024		Dollars			Percentage
	May 31, 2026		May 31, 2025		Dollars			Percentage
Device rental activities	$	1,~~807~~613,~~083~~095	$	1,~~429~~627,~~112~~286	$	~~377~~(14,~~971~~191	)		26(1	)%
Direct sales of goods and services		~~203~~218,~~075~~107		~~321~~227,~~856~~551		(~~118~~9,~~781~~444	)		(374	)%
Total revenues	$	2,010,158	$	1,750,968	$	259,190			15	%
	$	1,831,202	$	1,854,837	$	(23,635	)		(1	)%

Total revenue for the three-month period ended ~~November~~May 3031, ~~2025,~~2026 was $21,~~010~~831,~~158~~202which ~~which~~ represented ana ~~increase~~decrease of $~~259~~23,~~190~~635 or 1% compared to total ~~revenue~~ revenue of $1,~~750~~854,~~968~~837 for the three months ended ~~November~~May 3031, ~~2024~~2025. ~~There~~The ~~has~~decrease ~~been~~in revenue was attributable to a ~~15%~~significant ~~increase~~drop in the sales for one major customer due to their internal cost cutting initiatives. This major customer previously represented about 48% of the Company’s revenues asfor athe ~~result~~three months ended May 31, 2025 represented 21% of ~~higher~~the ~~rental~~Company’s revenues for the three months ended May 31, 2026. ~~activities~~The ~~growing~~Company ~~each~~managed ~~quarter~~to ~~through~~mitigate this reduction by gaining new customers and diversifying its customer base. For the ~~deployment~~three months ended May 31, 2026, two customers accounted for 36% of ~~new~~total revenue ~~earning~~and ~~devices~~for the three months ended May 31, 2025, two customers accounted for 65% of total revenue. The Company expects to see sales growth through new mobile products and software starting in the second quarter of this fiscal year. The mobile products will see a slow steady rollout over the fiscal year due to the capital intensive nature of these products.

Gross profit

Total gross profit for the three-month period ended ~~November~~May 3031, ~~2025,~~2026 was $1,~~173~~183,~~830,~~824which ~~which~~ represented ana ~~increase~~decrease of $~~126~~49,~~622~~677 compared to gross profit of $1,~~173~~233,~~830~~501 for the three months ended ~~November~~May 3031, ~~2024~~2025. The ~~gross~~decrease ~~profit~~is ~~increased~~consistent ~~due~~with to the ~~higher~~decrease ~~sales~~in revenues as well as changes in product mix. The gross profit % of 65% for the three-month period ended ~~November~~May 3031, ~~2025,~~2026 ~~was~~compared ~~slightly~~with ~~lower than~~ the gross profit % of 67% for the ~~prior year’s~~ ~~corresponding~~three month period ended May 31, 2025.

Operating Expenses

	Period				Change
	Three Months Ended November 30, 2025		Three Months Ended November 30, 2024		Dollars			Percentage
Research and development	$	1,096,970	$	579,045	$	517,925			89	%
General and administrative		2,737,329		2,733,547		3,782			0	%
Depreciation and amortization		36,358		106,261		(69,903	)		(66	)%
Operating lease cost and rent		61,295		57,875		3,420			6	%
Total operating expenses	$	3,931,952	$	3,476,728	$	455,224			13	%

-29-

Table of Contents

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended November 30, 2025, and November 30, 2024, were $3,931,952 and $3,476,728, respectively. The overall increase of $455,224 was primarily attributable to the following changes in operating expenses of:

● General and administrative expenses increased by $3,782. There were no significant changes. ● Research and development increased by $517,925 as the Company continues to develop new hardware and software solutions. ● Depreciation and amortization decreased by $60,903 due to changes in estimates for the allocation of revenue earning devices not in use. ● Operating lease cost and rent increased by $3,420 due to one more lease in the current period.

Other Income (Expense)

Other income (expense) during the three months ended November 30, 2024, and November 30, 2023, was ($2,099,300) and ($1,401,076), respectively. The $698,224 increase in other expense was due to higher interest expense and a loss on settlement of debt.

Net loss

We had a net loss of $4,730,800 for the three months ended November 30, 2025, compared to a net loss of $3,703,974 for the three months ended November 30, 2024. The increase in net loss of $1,026,826 is due to a number of factors: higher research and development expenses partially offset by higher gross profit in the three months ended November 30, 2025.

Results of Operations for the Nine Months Ended November 30, 2025, and 2024

The following table shows our results of operations for the nine months ended November 30, 2025, and 2024. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

Revenue

	Period						Change
	Nine Months Ended November 30, 2025			Nine Months Ended November 30, 2024			Dollars			Percentage
Revenues	$	5,753,744		$	4,277,951		$	1,475,793			34	%
Gross profit		3,878,818			2,860,255			1,018,563			36	%
Operating expenses		11,998,145			10,610,283			1,387,862			13	%
Loss from operations		(8,119,327	)		(7,750,028	)		(369,299	)		(5	)%
Other income (expense), net		(442,426	)		(4,078,628	)		3,636,202			89	%
Net loss	$	(8,561,753	)	$	(11,828,656	)	$	3,266,903			28	%

The following table presents revenues from contracts with customers disaggregated by product/service:

	Nine Months Ended November 30,		Nine Months Ended November 30,		Change
	2025		2024		Dollars		Percentage
Device rental activities	$	5,129,840	$	3,475,546	$	1,654,294		48	%
Direct sales of goods and services		623,904		802,405		(178,501)		(22	)%
Total revenues	$	5,753,744	$	4,277,951	$	1,475,793		34	%

-30-

Table of Contents

Total revenue for the nine-month period ended November 30, 2025, was $5,753,744 which represented an increase of $1,475,793 compared to total revenue of $4,277,951 for the nine months ended November 30, 2024. This 34% increase was because of higher rental activities partially offset by lower direct sales for the year to date November 30, 2025.

Gross profit

Total gross profit for the nine-month period ended November 30, 2025, was $3,878,818 which represented an increase of $1,018,563, compared to gross profit of $2,860,255 for the nine months ended November 30, 2024. The gross profit increased due to the higher sales. The gross profit percentage of 67% for the nine-month period ended November 30, 2025, was slightly lower than the gross profit percentage of 69% for the prior year’s corresponding period.

Operating Expenses

	Period				Change
	Nine Months Ended November 30, 2025		Nine Months Ended November 30, 2024		Dollars			Percentage
	Three Months Ended May 31, 2026		Three Months Ended May 31, 2025		Dollars			Percentage
Research and development	$	3885,~~104,303~~593	$	1,~~897~~087,~~165~~619	$	1(202,~~207,138~~026	)		64(19	)%
General and administrative		82,~~604~~907,~~371~~577		83,~~220~~232,~~564~~211		~~383~~(324,~~807~~634	)		5(10	)%
Depreciation and amortization		~~107~~32,~~379~~646		~~309~~34,~~699~~121		(~~202~~1,~~320~~475	)		(~~65)~~4	)%
Operating lease cost and rent		~~182~~67,~~092~~372		~~182~~58,~~855~~219		~~(763~~9,153	)		(016	)%
Total Operating expenses	$	11,998,145	$	10,610,283	$	1,387,862			13	%
Operating expenses	$	3,893,188	$	4,412,170	$	(518,982	)		(12	)%

~~General~~Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the ~~six~~three-month period ended ~~November~~May 3031, ~~2025~~2026 and ~~November~~May 3031, ~~2024~~2025, were $113,~~998~~893,~~145and~~ 188 and $104,~~610~~412,~~283~~170, respectively. The overall ~~increase~~decrease of $1518,~~387,862~~982 was primarily attributable to the following changes in operating expenses of:

● General and administrative expenses ~~increased~~decreased by $~~383~~324,~~807~~634. In comparing the ~~nine~~three months ended ~~November~~May 3031, ~~2025,~~2026 and ~~November~~May 3031, ~~2024~~2025 ~~the~~this ~~increase~~decrease ~~may~~was beprimarily ~~partially~~due ~~explained~~to by the following ~~increases~~decreases: wages and salaries by $~~337~~227,~~125~~585, ~~sub-contractors~~professional fees by $~~265~~45,~~245~~167, ~~and~~stock ~~office~~based ~~expenses~~compensation by $8819,~~545.~~847, ~~These~~production ~~were~~supplies ~~partially offset~~ by ~~decreases~~$45,525, inRMC ~~the following accounts: installation~~ costs by $8559,~~402~~948, ~~professional~~marketing ~~fees~~ by $5853,~~326~~486, ~~repairs~~freight and ~~maintenance~~duty costs by $3949,~~911~~508 and ~~freight~~dues and subscriptions by $6327,~~997~~858. ●These ~~Research~~costs ~~and~~were ~~development~~partially ~~increased~~offset by ~~$1,207,138~~increases ~~due to an increase~~ in ~~software~~subcontractor ~~development~~by $198,837 and ~~new~~with ~~products~~other ~~such~~net asG& ~~the~~A ~~ROAMEO~~account decreases. ● ~~Depreciation~~Research and ~~amortization~~development decreased by $202,~~320~~026 due to ~~due~~a todecrease ~~changes~~ in ~~estimates~~software ~~for~~development as the ~~allocation~~product ofis ~~revenue~~being ~~earning~~released. ~~devices~~● ~~not~~Depreciation inand ~~use~~amortization decreased by $1,475. ● Operating lease cost and rent ~~decreased~~increased by $~~763~~9,153 due to ~~the reduction of~~ one new lease ~~offset~~in ~~by the addition of another~~2026.

Other ~~Income (~~Expense)

Other ~~income~~ (expense) during the ~~nine~~three months ended ~~November~~May 3031, ~~2025,~~2026 and ~~November~~May 3031, ~~2024~~2025, was ($~~442~~3,~~426)~~006,474 and ($41,~~078~~415,~~628)~~349, respectively. The $31,~~636~~591,~~202~~125 increase ~~decrease~~ in other expense was primarily attributable to ~~the~~a ~~gain~~$885,525 onincrease ~~settlement~~in ofinterest ~~debt~~expense ofdue to an approximately $3338,~~740,185~~000 ~~offset~~increase in bydebt discount amortization expense, an approximately $204,000 increase in interest ~~expense~~on DVPO balance with the balance due to the switch to some notes (see Note 11) to compounding interest and interest on approximately $2.7 million increase in loans payable. The $707,600 loss on settlement was on the exchange of loans payable and accrued interest for the three months ended May 31, 2026

Net loss

We had a net loss of $85,~~561~~715,~~753~~838 for the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, compared to a net loss of $114,~~828~~594,~~656~~018 for the ~~nine~~three months ended May ~~November 30~~31, ~~2024~~2025. The ~~decrease~~increase in net loss of $31,~~266~~121,~~903~~820 is due to a number of factors: higher ~~gross profit and lower~~ other expenses ~~(due~~is toreduced ~~gain on settlement of debt) offset~~ by ~~higher~~lower operating expenses for the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~ 2026.

-31-

Table of Contents

Liquidity, Capital Resources and Cash Flows

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

As of November 30, 2025, we had a cash balance of $143,801, accounts receivable of $1,306,020, device parts inventory of $1,138,333 and $17,117,268 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.-31-

Table of Contents

As of May 31, 2026, we had a cash balance of $94,643, accounts receivable (net) of $974,897, device parts inventory(net) of $1,378,950 and $44,890,383 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

Capital Resources

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

	November 30, 2025			February 28, 2025
	May 31, 2026			February 28, 2026
Current assets	$	3,~~093~~005,~~439~~227		$	52,~~028~~935,~~543~~003
Current liabilities		1744,~~117~~890,~~268~~383			719,~~576~~952,~~681~~748
Working capital	$	(1441,~~023~~885,~~829~~156	)	$	(217,~~548~~017,~~138~~745	)

As of ~~November~~May 3031, ~~2025~~2026 and February 28, ~~2025~~2026, we had a cash balance of $~~143~~94,~~801~~643 and $~~865~~109,~~975~~043, respectively.

Summary of Cash Flows	Nine Months Ended November 30, 2025			Nine Months Ended November 30, 2024
Net cash used in operating activities	$	(7,451,163	)	$	(8,894,284	)
Net cash used in investing activities	$	(12,861	)	$	(77,868	)
Net cash provided by financing activities	$	6,741,850		$	8,950,457

Summary of Cash Flows

	Three Months Ended May 31, 2026			Three Months Ended May 31, 2025
Net cash used in operating activities	$	(2,759,307	)	$	(3,321,185	)
Net cash used in investing activities	$	(16,438	)	$	(9,720	)
Net cash provided by financing activities	$	2,761,345		$	2,789,777

Net cash used in operating activities.

Net cash used in operating activities for the ~~nine~~three months ended ~~November~~May 3031, ~~2025,~~2026 was $72,~~451~~759,~~163~~307 which included a net loss of $85,~~561~~715,~~753~~838, non-cash activity such as ~~the~~ bad debts expense of $~~141~~70,~~482~~000, reduction of right of use asset of $~~104~~38,~~585~~013, accretion of lease liability $7923,~~294~~281, stock based compensation of $~~241~~60,~~065~~508,~~penalty~~ ~~added to face value of loan of $16,560, gain on settlement of debt of $3,740,185,~~ change in operating assets and liabilities of $21,~~301~~255,~~738~~482, amortization of debt discount of $~~301~~385,~~615~~493, ~~increase~~ decrease in related party accrued payroll and interest of $~~108~~129,~~619~~687 and depreciation and amortization of $1545,~~555,817~~841 to derive the uses of cash in operations.

Net cash used in investing activities.

Net cash used in investing activities for the ~~nine~~three months ended ~~November~~May 3031, ~~2025,~~2026 was $1216,~~861~~438 which was the purchase of fixed assets of $1015,~~863,~~ 600 and ~~$1,998~~an ~~for~~ acquisition of ~~trademarks~~trademark of $838.

Net cash provided by financing activities.

Net cash provided by financing activities ~~was $6,741,850~~ for the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026 was $2,761,345. This consisted of share proceeds net of of issuance costs of 5$823,~~219~~480 ,~~853,~~ proceeds ~~from~~on ~~loans~~the ~~payable~~issuance of Series C Preferred Shares of $2200,~~375~~000,~~671,~~ ~~reduced~~proceeds byfrom ~~repayments on~~ loans payable of $~~728~~2,~~604 and the~~714,028 ~~redemption~~reduced ofby ~~Series~~repayments Con ~~redeemable~~loans ~~convertible~~payable ~~preferred shares~~ of $~~125~~976,~~000~~163.

Off-Balance Sheet Arrangements

None.

-32-

Table of Contents

Critical Accounting Policies and Estimates

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 28, ~~2025~~2026, as filed on ~~May~~June 299, ~~2025~~2026.

Related Party Transactions

During the ~~nine~~three months ended ~~November~~May 3031, ~~2025~~2026, the Company paid out gross payments to the CEO of $171,~~560,370~~105 offset by a bonus accrual of $~~750~~250,000, which yields a net change of $~~810~~178,~~370~~895 relating to deferred compensation for CEO. This was all in accordance with a December 2023 board action allowing for $1 million of annual discretionary compensation as well as a February 28, ~~2025~~2026, board action which provided an additional $1.5 million in compensation. During the three months ended May 31, 2025, the Company paid out gross payments to the CEO of $1,496,687 offset by a bonus accrual of $250,000, which yielded a net change of $1,246,687 relating to deferred compensation for CEO. The balance of deferred compensation for CEO was $1,~~392~~990,~~230~~751 and $21,~~202~~811,~~600~~856 at ~~November~~May 3031, ~~2025~~2026, and February 28, ~~2025~~2026, respectively

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable for a smaller reporting company.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Report on Internal Control over Financial Reporting

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of ~~November~~May 3031, ~~2025~~2026. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of ~~November~~May 3031, ~~2025~~2026, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

	1.	As of ~~November~~May 3031, ~~2025~~2026, we did not maintain effective controls over our control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
	2.	As of ~~November~~May 3031, ~~2025~~2026, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.

Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

-33-

Table of Contents

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

This item is not applicable to smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Each issuance of securities was issued without registration in reliance of the exemption from registration Section 3(a)9 of the Securities Act of 1933.

Date	Transaction	Consideration	Shares Issued
March 9, 2026	Debt exchange*	$224,000 in accrued interest exchanged for common shares at a fair value of $280,000 for a loss on settlement of debt of $56,000		7,000,000
March 12, 2026	Common share issuance	Rounding shares on reverse split		43
March 19,2026	Series C share issuance*	Issuance of 222 Series C Convertible Preferred including 22 Series C share Commitment fee for proceeds of $200,000		—
March 19,2026	Conversion of Series C Preferred Shares*	Conversion of 165 Series C shares for fair value of $216,810		13,550,625
March 20,2026	Debt exchange*	$112,000 in accrued interest exchanged for common shares at a fair value of $630,700 for a loss on settlement of debt of $518,700		7,000,000
March 25,2026	Convertible debt issuance*	$110,000 Convertible note that converts after 180 days at 80% of the lowest traded price 15 prior trading days		—
March 25, 2026	Convertible debt issuance*	$630,000 Convertible note that converts after 180 days with penalty at 20% of the lowest traded price 15 prior trading days. This loan was repaid May 5, 2026.		—
March 25, 2026	Common share issuance*	Commitment fee returnable to the Company as $630,00 debt was repaid on May 5, 2025		14,100,000
April 9, 2026	Convertible debt issuance*	$257,000 Convertible note that converts after 180 days at 65% of the average of the three lowest traded prices 10 prior trading days		—
April 20, 2026	Convertible debt issuance*	$277,778 Convertible note that converts at 75% of the lowest traded prices 10 prior trading days		—
April 20, 2026	Common share issuance*	Commitment fee on April 20 ,2026 convertible note		5,000,000
May 1, 2026	Convertible debt issuance*	$257,000 Convertible note that converts after 180 days at 65% of the average of the three lowest traded prices 10 prior trading days		—
February 11, 2025	Series C share issuance*	Issuance of 306 Series C Convertible Preferred for cash proceeds of $278,580
April 27, 2026	Debt exchange*	$185,600 in accrued interest exchanged for common shares at a fair value of $220,800 for a loss on settlement of debt of $35,200		8,000,000
May 4, 2026	Convertible debt issuance*	$700,000 Convertible note that converts at 65% of the lowest closing bid prices 10 prior trading days		—
May 4, 2026	Common share issuance*	Commitment fee issuable on May 4 ,2026 convertible note⁽²⁾		1,250,000
May 5, 2026	Debt exchange*	$80,000 in accrued interest exchanged for common shares at a fair value of $100,000 for a loss on settlement of debt of $20,000		5,000,000
May 6, 2026	Conversion of Series C Preferred Shares*	Conversion of 40 Series C shares for fair value of $52,560		3,285,000
May 12, 2026	Conversion of Series C Preferred Shares*	Conversion of 93 Series C shares for fair value of $122,202		7,637,625
May 27, 2026	Debt exchange*	$144,300 in principal and accrued interest exchanged for common shares at a fair value of $222,000 for a loss on settlement of debt of $77,700		12,000,000
May 29, 2026	Convertible debt issuance*	$138,889 Convertible note that converts at 65% of the lowest traded prices 10 prior trading days		—
March 1, 2026-May 31, 2026	Other registered sales	Various prices		36,786,492
	Number of shares outstanding May 31, 2026			388,482,589

* Sold under rule 144

-34-

Table of Contents

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

The Company has not defaulted upon senior securities.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable to the Company.

ITEM 5. OTHER INFORMATION

None.

-34-

Table of Contents

ITEM 6. EXHIBITS

Exhibit No.		Description of Document

3.1		Articles of Incorporation (1)

3.2		Bylaws (2)

14		Code of Ethics (2)

21		Subsidiaries of the Registrant (3)

31.1		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer. (3)

31.2		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial and accounting officer. (3)

32.1		Section 1350 Certification of principal executive officer. (3)

32.2		Section 1350 Certification of principal financial accounting officer. (3)

101.INS		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH		Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) (3)

(1)	Incorporated by reference to our Form 10-KT file with the Securities and Exchange Commission on March 12, 2018.

(2)	Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on August 4, 2010.

(3)	Filed or furnished herewith.

-35-

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Artificial Intelligence Technology Solutions Inc.
Date: January 14, 2026	BY:	/s/ Steven Reinharz
Date: July 14, 2026	BY:	/s/ Steven Reinharz
		Steven Reinharz
		President, Chief Executive Officer (principal executive officer)
Date: January 14, 2026	BY:	/s/ Anthony Brenz
Date: July 14, 2026	BY:	/s/ Anthony Brenz
		Anthony Brenz
		Chief Financial Officer (principal financial officer)

-36-

Filing Compare · Artificial Intelligence Technology Solutions Inc.